CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP010429	Spirosoma radiotolerans strain DG5A chromosome, complete genome	4 crisprs	cas3,cas4,cas2,cas1,cas6,cas5,cas7b,cas8b1,WYL,DEDDh,csa3,PD-DExK,Cas9_archaeal	1	0	1	0

Results visualization

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP010429_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010429_1

131565-131640

Orphan

Consensus_repeat	Method
GGTGGATATAATTTATTTCTTGGTA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP010429_1

>merge|NZ_CP010429|1|131565-131640|CRISPRCasFinder
GGTGGATATAATTTATTTCTTGGTACAAGAGCGGGTTACAATAATAGCACAGGTGGATATAATTTATTTTTTGGTA

>NZ_CP010429|1|1|131565-131640|CRISPRCasFinder
GGTGGATATAATTTATTTCTTGGTA	CAAGAGCGGGTTACAATAATAGCACA
GGTGGATATAATTTATTTTTTGGTA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010429.1\|WP_046375199.1\|124853_125876_+\|glycosyltransferase-family-2-protein	unknown	unknown	gnl\|CDD\|224137
NZ_CP010429.1\|WP_046375209.1\|141595_142741_-\|heparan-alpha-glucosaminide-N-acetyltransferase	unknown	unknown	gnl\|CDD\|226749
NZ_CP010429.1\|WP_046375205.1\|136141_137521_+\|sugar-transferase	unknown	unknown	gnl\|CDD\|274398
NZ_CP010429.1\|WP_046375200.1\|126058_127240_+\|oligosaccharide-repeat-unit-polymerase	unknown	unknown	unknown
NZ_CP010429.1\|WP_082111717.1\|133245_134364_+\|glycosyltransferase	unknown	unknown	gnl\|CDD\|340833
NZ_CP010429.1\|WP_046375210.1\|142870_143776_-\|prohibitin-family-protein	unknown	unknown	gnl\|CDD\|259799
NZ_CP010429.1\|WP_046375198.1\|122528_123845_+\|oligosaccharide-flippase-family-protein	unknown	unknown	gnl\|CDD\|240533
NZ_CP010429.1\|WP_046375211.1\|144088_144547_-\|DUF1573-domain-containing-protein	unknown	unknown	gnl\|CDD\|377880
NZ_CP010429.1\|WP_046375201.1\|128388_130320_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|380473
NZ_CP010429.1\|WP_046375208.1\|140539_141460_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|223730
NZ_CP010429.1\|WP_046375197.1\|121437_122388_+\|GDP-mannose-4,6-dehydratase	unknown	unknown	gnl\|CDD\|224014
NZ_CP010429.1\|WP_046375195.1\|117930_120327_+\|SLBB-domain-containing-protein	unknown	unknown	gnl\|CDD\|224512
NZ_CP010429.1\|WP_046375203.1\|132603_133128_+\|T9SS-type-A-sorting-domain-containing-protein	unknown	unknown	gnl\|CDD\|275036
NZ_CP010429.1\|WP_046578863.1\|134478_135948_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379441
NZ_CP010429.1\|WP_046578862.1\|127285_128368_+\|glycosyltransferase-family-4-protein	unknown	unknown	gnl\|CDD\|340838
NZ_CP010429.1\|WP_052731025.1\|123841_124837_+\|class-I-SAM-dependent-methyltransferase	unknown	unknown	gnl\|CDD\|372616
NZ_CP010429.1\|WP_046375206.1\|137560_139081_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|379441
NZ_CP010429.1\|WP_046375207.1\|139220_140468_+\|serine-hydrolase	unknown	unknown	gnl\|CDD\|365903
NZ_CP010429.1\|WP_046375196.1\|120347_121433_+\|LPS-biosynthesis-protein	unknown	unknown	gnl\|CDD\|225747
NZ_CP010429.1\|WP_046375194.1\|114318_117711_-\|preprotein-translocase-subunit-SecA	unknown	unknown	gnl\|CDD\|237256

Protein	Function_ID	Function_description	E-value
NZ_CP010429.1\|WP_046375199.1\|124853_125876_+\|glycosyltransferase-family-2-protein	gnl\|CDD\|224137	COG1216, COG1216, Predicted glycosyltransferases [General function prediction only].	3.40699e-39
NZ_CP010429.1\|WP_046375209.1\|141595_142741_-\|heparan-alpha-glucosaminide-N-acetyltransferase	gnl\|CDD\|226749	COG4299, COG4299, Uncharacterized protein conserved in bacteria [Function unknown].	5.65704e-44
NZ_CP010429.1\|WP_046375205.1\|136141_137521_+\|sugar-transferase	gnl\|CDD\|274398	TIGR03025, EPS_sugtrans, exopolysaccharide biosynthesis polyprenyl glycosylphosphotransferase. Members of this family are generally found near other genes involved in the biosynthesis of a variety of exopolysaccharides. These proteins consist of two fused domains, an N-terminal hydrophobic domain of generally low conservation and a highly conserved C-terminal sugar transferase domain (pfam02397). Characterized and partially characterized members of this subfamily include Salmonella WbaP (originally RfbP), E. coli WcaJ, Methylobacillus EpsB, Xanthomonas GumD, Vibrio CpsA, Erwinia AmsG, Group B Streptococcus CpsE (originally CpsD), and Streptococcus suis Cps2E. Each of these is believed to act in transferring the sugar from, for instance, UDP-glucose or UDP-galactose, to a lipid carrier such as undecaprenyl phosphate as the first (priming) step in the synthesis of an oligosaccharide "block". This function is encoded in the C-terminal domain. The liposaccharide is believed to be subsequently transferred through a "flippase" function from the cytoplasmic to the periplasmic face of the inner membrane by the N-terminal domain. Certain closely related transferase enzymes, such as Sinorhizobium ExoY and Lactococcus EpsD, lack the N-terminal domain and are not found by this model.	3.02926e-109
NZ_CP010429.1\|WP_046375194.1\|114318_117711_-\|preprotein-translocase-subunit-SecA	gnl\|CDD\|237256	PRK12901, secA, preprotein translocase subunit SecA; Reviewed.	0
NZ_CP010429.1\|WP_082111717.1\|133245_134364_+\|glycosyltransferase	gnl\|CDD\|340833	cd03804, GT4_WbaZ-like, mannosyltransferase WbaZ and similar proteins. This family is most closely related to the GT4 family of glycosyltransferases. WbaZ in Salmonella enterica has been shown to possess mannosyltransferase activity.	5.79814e-99
NZ_CP010429.1\|WP_046375210.1\|142870_143776_-\|prohibitin-family-protein	gnl\|CDD\|259799	cd03401, SPFH_prohibitin, Prohibitin family; SPFH (stomatin, prohibitin, flotillin, and HflK/C) superfamily. This model characterizes proteins similar to prohibitin (a lipid raft-associated integral membrane protein). Individual proteins of the SPFH (band 7) domain superfamily may cluster to form membrane microdomains which may in turn recruit multiprotein complexes. These microdomains, in addition to being stable scaffolds, may also be dynamic units with their own regulatory functions. Prohibitin is a mitochondrial inner-membrane protein which may act as a chaperone for the stabilization of mitochondrial proteins. Human prohibitin forms a hetero-oligomeric complex with Bap-37 (prohibitin 2, an SPFH domain carrying homolog). This complex may protect non-assembled membrane proteins against proteolysis by the m-AAA protease. Prohibitin and Bap-37 yeast homologs have been implicated in yeast longevity and in the maintenance of mitochondrial morphology.	1.68875e-61
NZ_CP010429.1\|WP_046375198.1\|122528_123845_+\|oligosaccharide-flippase-family-protein	gnl\|CDD\|240533	cd13128, MATE_Wzx_like, Wzx, a subfamily of the multidrug and toxic compound extrusion (MATE)-like proteins. Escherichia coli Wzx and related proteins from other gram-negative bacteria are thought to act as flippases, assisting in the membrane translocation of lipopolysaccharides including those containing O-antigens. Proteins from the MATE family are involved in exporting metabolites across the cell membrane and are often responsible for multidrug resistance (MDR).	9.40885e-41
NZ_CP010429.1\|WP_046375211.1\|144088_144547_-\|DUF1573-domain-containing-protein	gnl\|CDD\|377880	pfam07610, DUF1573, Protein of unknown function (DUF1573). These hypothetical proteins, from bacteria such as Rhodopirellula baltica, Bacteroides thetaiotaomicron, and Porphyromonas gingivalis, share a region of conserved sequence towards their N-termini.	2.29889e-49
NZ_CP010429.1\|WP_046375201.1\|128388_130320_+\|hypothetical-protein	gnl\|CDD\|380473	cd20481, phage_tailspike_middle, N-terminal and middle domains of tailspike protein in Acinetobacter bacteriophages. This model describes the middle beta-helical domain of Acinetobacter bacteriophage tailspike proteins, as well as a separate N-terminal domain that does not appear to be part of the beta-helical substructure. The N-terminal domain may be involved in virion binding, and the molecules form a homo-trimeric arrangement. A C-terminal domain that may be involved in receptor binding is omitted from the model.	8.51641e-08
NZ_CP010429.1\|WP_046375208.1\|140539_141460_+\|alpha/beta-hydrolase	gnl\|CDD\|223730	COG0657, Aes, Esterase/lipase [Lipid metabolism].	7.04909e-26
NZ_CP010429.1\|WP_046375197.1\|121437_122388_+\|GDP-mannose-4,6-dehydratase	gnl\|CDD\|224014	COG1089, Gmd, GDP-D-mannose dehydratase [Cell envelope biogenesis, outer membrane].	9.30364e-149
NZ_CP010429.1\|WP_046375195.1\|117930_120327_+\|SLBB-domain-containing-protein	gnl\|CDD\|224512	COG1596, Wza, Periplasmic protein involved in polysaccharide export, contains SLBB domain of b-grasp fold [Cell wall/membrane/envelope biogenesis].	2.40989e-20
NZ_CP010429.1\|WP_046375203.1\|132603_133128_+\|T9SS-type-A-sorting-domain-containing-protein	gnl\|CDD\|275036	TIGR04183, hypothetical_protein, Por secretion system C-terminal sorting domain. Species that include Porphyromonas gingivalis, Fibrobacter succinogenes, Flavobacterium johnsoniae, Cytophaga hutchinsonii, Gramella forsetii, Prevotella intermedia, and Salinibacter ruber average twenty or more copies of a C-terminal domain, represented by this model, associated with sorting to the outer membrane and covalent modification.	0.00257673
NZ_CP010429.1\|WP_046578863.1\|134478_135948_+\|hypothetical-protein	gnl\|CDD\|379441	pfam14052, Caps_assemb_Wzi, Capsule assembly protein Wzi. Many bacteria are covered in a layer of surface-associated polysaccharide called the capsule. These capsules can be divided into four groups depending upon the organisation of genes responsible for capsule assembly, the assembly pathway and regulation. This family plays a role in group 1 capsule biosynthesis. It is likely to be involved in the later stages of capsule assembly. It is likely to consist of a beta-barrel structure.	2.89638e-58
NZ_CP010429.1\|WP_046578862.1\|127285_128368_+\|glycosyltransferase-family-4-protein	gnl\|CDD\|340838	cd03809, GT4_MtfB-like, glycosyltransferases MtfB, WbpX, and similar proteins. This family is most closely related to the GT4 family of glycosyltransferases. MtfB (mannosyltransferase B) in E. coli has been shown to direct the growth of the O9-specific polysaccharide chain. It transfers two mannoses into the position 3 of the previously synthesized polysaccharide.	1.96116e-94
NZ_CP010429.1\|WP_052731025.1\|123841_124837_+\|class-I-SAM-dependent-methyltransferase	gnl\|CDD\|372616	pfam13489, Methyltransf_23, Methyltransferase domain. This family appears to be a methyltransferase domain.	3.3638e-17
NZ_CP010429.1\|WP_046375206.1\|137560_139081_+\|hypothetical-protein	gnl\|CDD\|379441	pfam14052, Caps_assemb_Wzi, Capsule assembly protein Wzi. Many bacteria are covered in a layer of surface-associated polysaccharide called the capsule. These capsules can be divided into four groups depending upon the organisation of genes responsible for capsule assembly, the assembly pathway and regulation. This family plays a role in group 1 capsule biosynthesis. It is likely to be involved in the later stages of capsule assembly. It is likely to consist of a beta-barrel structure.	1.69757e-24
NZ_CP010429.1\|WP_046375207.1\|139220_140468_+\|serine-hydrolase	gnl\|CDD\|365903	pfam00144, Beta-lactamase, Beta-lactamase. This family appears to be distantly related to pfam00905 and PF00768 D-alanyl-D-alanine carboxypeptidase.	1.49333e-66
NZ_CP010429.1\|WP_046375196.1\|120347_121433_+\|LPS-biosynthesis-protein	gnl\|CDD\|225747	COG3206, GumC, Uncharacterized protein involved in exopolysaccharide biosynthesis [Cell envelope biogenesis, outer membrane].	1.23673e-08

>NZ_CP010429.1|WP_046375201.1|128388_130320_+|hypothetical-protein
MKKILFLVLLTSSLFAQVPTNLNNLKAYINQKLGPAHNAQVSNQKIQDITSEITDQLIAIDQSKISTISLSALRSLKSNGPAAVYILDAGKQGQFLLDVTDNTTVDNSATVIVTAKGQRYKRDIHIVRVKQFGAKGDRVTDDTQAIRLAMNYCKALKKAVLVFEHNASYKITGTVLYDLSAQSRIRNNDYSLTIQGNNATIWVVGTTNSFWAFNFTFSPQPEQDAKLQINDLWFQTDNVNRPNGILTKYAHFFEIHNVVFFQLWKGFRIENAGMSAVTNTYAFGCQTGFDSELNRDTKFDNCLAFGCETGFFAEGANDGGGAGGLGIVNCYGINNGVNFNLRRLQTAKFTNIVSDVPVNKGILIESCNFLQVNNVLCGPNQKGSKIAFHVTKASNGTDNDYCQFNSVIAENEIVFDHSNYSSVSNLVSTHVFNSSSGAAFDISNSTELTINNAKFRDLSSANSLRVRPNSSRIVFNAGEYDKRLYIEGVNRLGNNIINGSIMKEDVFFENAPLNNESGYYYLSNKVKTIKGGFLLPNIVLKETPMAKAGQVINFDINAVIKRPSIGGAYKATFVSSNGIFGSFGTTVIEVIRNYDNTQAAITSNIPSSSVQITIPSNNIIRFTCNATNAGTIAKLTLIYVEEI
>NZ_CP010429.1|WP_046578862.1|127285_128368_+|glycosyltransferase-family-4-protein
MILNSGIGIYIENFVKGLANTGKYSIVLLGSEKELSSVFDNNHYYKIIDIDVPIYSILEQLYLPFVVPKCDIFWSPHYNIPLLPIRAKKRLVTIHDTYHITFGNTLGPFKRLYAKLMLKIAVALSDIVFTVSEFSRSEIYRHVNTKKNIISIYNGIDLNKFSINNNSHIVYKVREKLSLPHKYILFVGNVKPNKNIVRLLLAFKKLISKDFNYCLVIVGKKEGFINGDEEVFDLLKNDEILSSRVTFTGYVDIMDLPILYQSAAVLAFPSIYEGFGLPPLEAMACGCPVIVSSTSSLPEVCGEKAALYINPLEVDSIADGLQSVLLNENIRKQLILEGSLRCKEFSWSKSVSKFIVSIER
>NZ_CP010429.1|WP_046375200.1|126058_127240_+|oligosaccharide-repeat-unit-polymerase
MYPFAASEFNIISTGPVISLIQEYVEKAYILSITGYFFTYIGFYACNNRSLGHKFHRIINTFSLIGEKLITHAIQSKPIILFLSWVLSLTTILGLLYAIAIFGFSFNLRSAFYAENSLLKSFFNLWTALFTNISGFIIIRYLQKREKIFLYIYIFIAVFAIFNGARGTLIIPFLNSFLLYLVGKKNNIKFKYFFYLGSVALFLIFALENLRRVDPVSESFSAIYSFFYGNSFSDVRDFAWILAYWDDNLLLGKSYLSAFMSFIPRSLSEFRSVYAFGVYTDLMVGFDPTLHPGLRPGRFGEIYFNFGVLGIVVLGFLGGYVMRLADIKIKKLATKPRQNYIAMYSTTFLTFFISQFYITAGFWSFYVLILILAGSFLLKRFIEALSLNSSVHH
>NZ_CP010429.1|WP_046375199.1|124853_125876_+|glycosyltransferase-family-2-protein
MVYIIILNYNGWRDTIECLESLLKIDNCNFKIIVIDNLSTDDSLSKIISWSKDKFLIDSCTIESEFDLMYIKHDFSDKLSDSSLGAKSYSFYQSKQNGGYSAGNNNGIRHAMENSDAEYIWILNNDTIVDKNSLGEMLNVYALAEKRKLKLGIVGCKLLYYNNPNVIQCLGGVLYNPYIGIIRQVGNNEADTGTIKYNIKPKVSYIPGTSMLVSVNFVKDVGLLSEEYFLYFEELDWTKRGEKRGWQIDYTLEAFVLHKEGGTINKDNYLNKSALSDYCFLRSKLLYTRKYENSFCKVTIFLGVILSFLLRIYKGQFDRILTMARIVFNPNSRFFLPKID
>NZ_CP010429.1|WP_052731025.1|123841_124837_+|class-I-SAM-dependent-methyltransferase
MNKTNEKVCRICGSSDLTTFNVREMMFGTKVEFLYAECKTCGCFQLCDIPKDMSPYYPNSYYSLLASPDDNYKNPLEKITRKIRDKYAVSSKGLLGKLLYKFYPNETIMSLAQAKIKSTTRILDVGCGKGQLLYSLRELGYENLLGVDPYLEQDIKYSNGLAIQKKPIDQIEGEWDLIMLHHVIEHLESPALTLQVIDKHLSKDGICLIRTPIVPCLVWDQYNSDWIQLDAPRHLTIFSVLGIKCLLENTNLRIDKAFYDSTTLQFWGSEQYKNDISLWAENSYRINAEKSIFSKEVIKDFQRQTTNLNKMSALEGNKGADQIVIYLTHKS
>NZ_CP010429.1|WP_046375198.1|122528_123845_+|oligosaccharide-flippase-family-protein
MKLVLYDLYHKIKSLRSYKPIALNFLALSTVQLTNFIVPILSFPYLIKILGSSNFGIVSYGLTIMLYFNTFTDYGFNLSSTREVSMKQGDVKQLSIIFCNVLATKAILFLISIIILLILIILLPKFQKESELFLIGIIYIFGNAIMPVWYFQGIEKMNHLTVANLISKIILITLIYLIIKSPQDYKYVLGIYGSANLISGIYGIYIAYSKYGLLVVLPKWKNIFNNLRDGWSMLISNLSIIGFSSSNIIILSFFVSDKIIGNYSIAEKIIFALWQILSVFSQATFPYVCKLIQSNFLEVKKYIRNIYLPFNLFVLMMCICLFTYAEQIVFWTTNSLERQTIDLLKLMSPVIYIVCLNIPAYQILLAKNLKRQYAIIFNSATFINLLACPILVRVYGVNGAALSLLLIQILVTCSLHTVLEIKMGKYSIWRKQTNIQSL
>NZ_CP010429.1|WP_046375197.1|121437_122388_+|GDP-mannose-4,6-dehydratase
MKTALICGVSGQDGAYLAKLLLDRGYKVFGGSRDAQMSSFSSLNKLNIRQDIETVSISISDFRSVLQTLQRTKPDEVYNLAGQSSVGLSFEQPVETLESISVGTLNLLEAIRFTGNPIRFYNAGSSECFGDTGSVAADEMTPFRPRSPYGVAKAAAFWQVANYREAYQLHASTGILFNHESPLRPERFVTQKIVSAACRIANGSKEVLTLGNIDVARDWGWAPDYVEAMWLMLQQNQADDYVIATGQTRKLRDFIDIVFKTVGLSWEEHIHIDTGFFRPTDIAEGHANPKKAHHQLNWKARHNMDKVAQMMIYQKL
>NZ_CP010429.1|WP_046375196.1|120347_121433_+|LPS-biosynthesis-protein
MSVTETKKEKNTEDEEIEIRLKDIVQFLKTSRKTVIICCLTFLLIGALYSYSKPDLYSAQVTVLPEIQAKVGGLGGLGSLAGLAGIDIANVPNGNTDAIRPDIYPDVLQSTPFALQLLQKPVYSQLLGKEASLQIFIEEQSKQSWLGGLISSDDSNNKEGVLPDPKNRSRALQITKKQEDLIKRVHNAVSATYDKKTGVITVAATFSDRVVAASVARLSLEYLTNYMISYRTGKARNQVHFLTRQVDDAKNRYQRAEYALSNYRDQNRSLYLNTAKIEEQRLQADFILTQSVFNDLSKQLEQAKIKVSEESPVFKILEPARIPLKKSAPKRSLIIVGFAIAGIFLGLFIQVVRLFILNSKM
>NZ_CP010429.1|WP_046375195.1|117930_120327_+|SLBB-domain-containing-protein
MFLKDKLSRFTHQIRSCHVVFILLVLTGSYQAIAQQPRSRVDQLSDEDVQNFYRKAQASGLSEVQIEQAAMSQGYTLDDIAKMRKRMAQIRTLTSLPQNNLPPESFKGRSFPSDLSVRRDTLLPDTMRRDTSRKLKVFGASLFENAKMSFEPNLRIATPRNYVVGPDDEIKVDISGASTGAFDLKVSPDGTVKVPDLAPIFVSGLTIEQAEQRIIARLRQGGYQGLGKAGSGTSANVSLTNIRSIRVILVGEVVRPGTYTISSLGSVLNALYLAGGPNPETGSFRKIQVIRGNRVVRTLDLYDFILRADQRDNIPLRDQDVIRVADYETHVELNGQVRRPAIFEVLPGETLKTVLGFAGGFGEDAYRASITLRRNTARERRIVTITEEQIATFVPKAGDKYNVGKILERYENRVQIAGAVMRPGDYALEPGLETVKQLITRAEGLRKDAFTNRATIIRERADMDRENLSFDLGKLVRGEVADIPLQSQDSLTVLSIRDLREAYYVTIEGAVNRPDTVEFVANMSVADLIAHAGGFQEGAKPNLVEVARRIRQDSVGVRTTTQEIHRFSIDRNLKITAMEGSADNASFRLQPFDIVYVRTSINYEEQRQVNVYGEVMQPGNYVIYNRQERIGDIIQRAGGLKPEAYLAGAQFKRKGQLIGNDLRNLIADPGGEENLLLQDEDTLFIPRRSEIITVQGAVLNPASVSYKADYSFNDYISEAGGFTDNARQRKAYVNYPNGRKDRTHNFLFFTSRPHVEPGSTIVVPFKPIDSNRLSSAERIGILSLLATVSIALINVILR
>NZ_CP010429.1|WP_046375194.1|114318_117711_-|preprotein-translocase-subunit-SecA
MINLIAKFFGTKSQRDIKELLPYVEKVNAEFAQLKELSNDELRRVSAELKAHIAQELGGIDAQLAELNDLGSHADVDVNEKERIFNQIDKLEADRNTELERVLLDILPRAFAVVKETARRFAENEQLTVTTTDFDREIASRKRNVVIDGDQAHWANTWDAAGTPIKWDMVHYNVQIIGGVVLHQGKIAEMATGEGKTLVATFPAFLNGLAGRGVHIVTVNDYLAKRDSEWMAPLFEFHGMRVDCIDKHQPNSEQRKQAYLADITYGTNNEFGFDYLRDNMARETGELVQRKHHYAMVDEVDSVLIDDARTPLIISGPVPRGDEQDYIELKPRVSRLVEAQRKLVYDYLNDAKKKIAAGDEKEGGLSLFRAYRGLPKHKPLIKFLSETGNKALLQKTESIYLAENQKLMPEADAPLYFTIDERHNGIDLTEKGIDYITGSGEDPNFFILPDLSIDLNAIDKDDEFSEQEKILHKESVVRDYAVKTQRINTVNQLLKAYCLFEKDTEYVIMDGKVKIVDEQTGRIMEGRRWSDGLHQAVEAKENVKVEDATQTYATVTLQNYFRMYHKRAGMTGTAETEASEFWQIYKMDVVVIPTNRAISRADEEDKVYRSVREKYNAVVDEITSLVEKGRPVLVGTTSVENSELLSRLLTLRKIQHQVLNAKYHQREAEIVASAGFPGTVTIATNMAGRGTDIKLTPESKAAGGLAIIGTERHESRRVDRQLRGRAGRQGDPGTSQFFVSLEDSLMRLFGSERIAKVMDRMGLEEGEVIQHSMITKSIERAQKKVEENNFGIRKRLLEYDDVMNYQREAIYKRRRNALFGDRLPLDIANTMYDVVEETVNNAEGNYEEIKLQLLTTLGLSPALSADEFNRLKKPDQIRRLYEEAEANYQAKNQAIAEKALPVLTQVLADQGHQIKNIVVPFSDGIHELTVVSDLRKAVESGAREIVTEMEKAVTLSVIDQEWKEHLREMDDLKQSVQNAVFEQKDPLLVYKFESVELFKRFLNKVNFDTISFLTKADIPAQDAEEVQQEIRQAPVQQRPKPQPQLHTNMEDFDDDHLATGPEEYARRMAENDAMGAGAPPMPPRQAPMRVAKLDRNARVNVQYVDGSVKRDVKFKTVENDVVSGKAMLID
>NZ_CP010429.1|WP_046375203.1|132603_133128_+|T9SS-type-A-sorting-domain-containing-protein
MRIILSIVGCLLMVKAAAQEIRKQQYIQLTYTPNRAYVEQATEKIAAVNTVLARTTVEYRAGHTIELLPGFEAKQGSVFTAHVQEVHDASLRLVAFPNPFDKSTTISFDLPETGVINLFVVNEKGQIVEHLLENSQLPAGKHQFEWKADAHSSGIYIPVLKTGRQQVSSRVVKK
>NZ_CP010429.1|WP_082111717.1|133245_134364_+|glycosyltransferase
MCRAGGEQVALCFHKAFPDAPIYTQCYRPELTFPEFQSCDIRTTWLQRIAKTDDTMKKLFFPLGVWAMQSHDLTEFDVVLMSGTHCAKYVKVRPDALVISYSFTPFRLAWDPESYAQYSKSTGLARKLFDVVVQKLRAIDFEAAQRPNFFVAMTEETKERLQTAYQIKQEVQIINPPVNTRNFHISDLPKSYYLVVSRLEYYKKVDLVIEAFNRLGYPLVVVGKGLQEDEIKAGAKSNVQFMSGLSAKELADVYANCRAFIFPQHEDYGITPLEANAAGRPVIAYGTGGVLATQIPVMDEPSRATALFFSNQTVEDLTNAVKQFETIEHRFDPSFIRSHAESFDESKFIDQIRVFVAGKFAQHRKTKSSTIK
>NZ_CP010429.1|WP_046578863.1|134478_135948_+|hypothetical-protein
MITLNAQPIRQPSHYFGEVGTYQSSSTETPFWLRSNQYGVVPNRSPVLTLRAGIYSDYDSSRHSTGRWKTSKYDFGYGINVVANANRNELAYERNVLLPEAYVKVRRGIWELYIGRRREKFGLADSTLSTGSYAWSGNAMPVPKIQLSIPVFTPIGFTKGWLAVQGTFAHGYLDANGFVSNTMLHQKSLYLRFGREKDVVRLYGGFNHQVVWGGHTDKLKGTGLVPDDGKLPSTLRDYYYVVVGDRFSRTDSSAYTNFEITNRVGNHLGSIDIGAEIDLVRHTLYFYRQNIYEDGSLFYLINIADGLNGVRIRRNDPKAIVRDILFEFLNTTSQGGPEFIIGDPYKQGKDDYFNHQQFREGWAYRQHTIGTPFIPPALGPQDQYPDGTFTANNRVYVFHAGLAGSLFTRWRVLNGPLAYQVKLSYSHNLGTYNNPFTVPKNQFSTYFNVVAPLDILGGVQLTASVATDVGSLYQNGVGSFISIRKSWGK
>NZ_CP010429.1|WP_046375205.1|136141_137521_+|sugar-transferase
MRHRYSILFFPLHVIVDFLSLNVAFVGAYWLKFQQVEHVTQPPYAAFWALFNMIWLLEILIIKPYTFPRQLFKVYHLIKKLLILMAIHIAIISIYWVAVKGYYYSREHLLYTYILFTGMALAFRVGSLVFLREYRARGYNNRRYIIVGYGKLAVSIQNFYNAHPEMGFRFYGYFDQPSAENGGLLKGSYDDLSAYIKQEDIDCVYCCMPYIDNRYLKIIAENAEAADYQVKLLVDFRGFLARGASVEYHDFLPVLNLSSQMLADFQVNTLKRSFDLLFSIAALGLGMPLFIVLATITKFTSAGPIFYAQERIGRGGKPFKIYKFRSMYVDSEKSGPVLSGGLLDNRITPWGRFMRSTRLDEVPQFYNVLIGDMSVVGPRPERQHFIDQIVEIAPEYRSLLKVKPGITSIGQIKYGYASNIDEMVQRLRYDLLYPKRRSFLFDMWIIAQTLRVMAQGRGK
>NZ_CP010429.1|WP_046375206.1|137560_139081_+|hypothetical-protein
MRFLFLSIWYGTIVAASCTLGFGQRVSQYQVETGALLSSDQTPFWLRANQYGVVPLKNPAFRLNASLHSDYRLADSLGHKPIADWGYGLNMVANLGATNQFLFPEAYVKGRLGAFELYAGRRKEIIGLVDTLLTSGSYIWSGNTVPFPKIQLAVPVFTPLPFTKGVLSVMGTFSHGWFENAGRLVQGSYLHQSSLYGRIGKSSWRVRFYGGFNHQVMWGGHSNYLDNTVSANGKLPSSIKYFPAVVLGTRNPFPDDQSIQTLSHFEENRVGNHLGSVDLAIDVNLNHWNLFVYRQFLYDDGSLFYGTNLVDGLNGLRIRNRDQPSGTAFFLKQITLEYLFTGSQGGDLFVLEDPAKRGRDDYFNNSQFIDGWTYFGRTIGTPFLTPQQEVSSTLPPRYGIANNRVSAYHFGLSALIANKVDIIAKLSYSLNAGTYAIPYLTIPTQFSGLLTASVPVGLFGGTVLGGSLAVDSGKLLPNSVGGYISLRKTGVLGGNRRPMVSPRRGF
>NZ_CP010429.1|WP_046375207.1|139220_140468_+|serine-hydrolase
MVRMNSFLSWFCVLVLIGVGISCGQDQKNLNKSARALRSCADEQILTSAEQTAIRQQINAEGKSRRIEEIFRQKVRGGLNGNVLVAQKGIILYKNCFGLGHFERNQRDTLVEDSKFQLASLSKTFTAVGTLKLIEAGKLKFEDTIQRFYPDFPYHGITVRELLSHRSGLPNYQYAFDDSMKVNFYKKEKPYPSNATIMHWFATVKPTPKAYNIPGRGFSYSNTNYMVLASIIEKVTGQSYEAFIQKNIFEPLGMHQTFVATTKNDSINHHRTAGYQWNRRIPKDYYDDVVGDKGIYSTTGDLFRWYRALNGDCLLPKKILAEAFVPRSFEKKGAKNYGYGFRMMLNDNKQPEYIYHSGWWKGYNTMFWFSPKDEYVIIILGNRYNTTVYQVKELIEVLHSGSNDKVSTEESEVEI
>NZ_CP010429.1|WP_046375208.1|140539_141460_+|alpha/beta-hydrolase
MRSLLFSMLLATVLPKLALAQEIIKLWPDEAIPNAIVGTQITEKSETDANDILRISNVSVPTLTVYLPPKGKATGTAVMICPGGGYGILAASHEGSDVARWFNDMGVAAFVLKYRLPNPAIMTNQQEVPLLDAMQGLTLIRKGAARYGIDSNKIGVMGFSAGGHLASTLATHYNKGPKASEQAKPNFTILLYPVITFGEKAHAGSRNNLLGKLASSPEMVAYYSNELQVTAQTPPTFLVHAEDDKAVPVENSIDFYLACLKSGVPAEMHLYPSGGHGFGLRTAKFGSLNAWPDACKAWLMSLYAKK
>NZ_CP010429.1|WP_046375209.1|141595_142741_-|heparan-alpha-glucosaminide-N-acetyltransferase
MQPTTSTQEPALAQPVPIRRLLSLDALRGFDMFWIMGGEEVFHVLAKTTGWAWAIFLADQFTHVTWNGFRPYDCIFPLFLFLAGVSTPYSLGSRLAKGDNRAMLARKVITRGLILVVLGIIYNNGLFMKPFAEMRFGSVLARIGLAGMFAQLIYLYVRSERARYGIFIGILLLYWAMLMLIPVPGFGAGNLTMEGSLVGYVDRLFMPGRLYKVVHDPEGLLSTLPAICTGLLGVFAGTVLRRHNLTDTRKIQQLILAGVSCVALGWVWNSVFPVNKNLWTSSFVLVAGGWSLLILSLFYWIIDVKNWRRWTFFFVVIGMNSILIYLAGRVIDFEYAAHFLFAGLLHFFSEPVQTVGSVVAFLAVKWGFLYFLYKKKTFLRV
>NZ_CP010429.1|WP_046375210.1|142870_143776_-|prohibitin-family-protein
MFFLVLGFLVLVAGFAINTPAIAFSHYSRPTKVVGVILIVLGFVTSSIRQIDAGQVGVTSIFGNVSDRPLSAGLNFVNPLANVTEFDIKTQNYTMSASHDEGQKAGDDAIRVLTADGLEVVIDLTVLYRVVSADAPKIYSEIGTDYMDKIVRPITRTRIRDNAVYYDAIALYSTRRDEFQTRIYKTIEADFRKRGLLLEQLLIRNIDLPASVKKTIESKINAEQDAQKMQFVLQKEKQEAERKRVEAQGIADYQKILSTGLSDKQLQYEQIKAQRELAASPNAKIVIMGSRGNVPMILSDK
>NZ_CP010429.1|WP_046375211.1|144088_144547_-|DUF1573-domain-containing-protein
MKKTFSLFVALFMLVAVSYAQKGVLKFTKETHDFGKVEQGKPVTHVFEFKNTGTDPVVINDAQASCGCTKPSFSREPIMPGKTGSISATYNAAAAGPFNKSVTVTSNAEAGQAVLYLKGEVVSAAAAAETAAAPAATTPAAKDKKKSTKTSR

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010429_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010429_2

717855-717953

Orphan

Consensus_repeat	Method
CTCATCGAATTTGGTGTATTTAAAGTCGGCATA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP010429_2

>merge|NZ_CP010429|2|717855-717953|CRISPRCasFinder
CTCATCGAATTTGGTGTATTTAAAGTCGGCATATCGCTCGAAGGCTACCCTCCGAAACGACGATGACTCATCGAATTTGGTGTATTTAAAGTCGGCATA

>NZ_CP010429|2|2|717855-717953|CRISPRCasFinder
CTCATCGAATTTGGTGTATTTAAAGTCGGCATA	TCGCTCGAAGGCTACCCTCCGAAACGACGATGA
CTCATCGAATTTGGTGTATTTAAAGTCGGCATA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010429.1\|WP_046375576.1\|714396_714813_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_082111497.1\|727101_728691_+\|sulfatase	unknown	unknown	gnl\|CDD\|293751
NZ_CP010429.1\|WP_148562533.1\|723938_726821_-\|DUF11-domain-containing-protein	unknown	unknown	gnl\|CDD\|307488
NZ_CP010429.1\|WP_046375585.1\|721308_721794_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046375571.1\|708622_709285_+\|endonuclease-III	unknown	unknown	gnl\|CDD\|223255
NZ_CP010429.1\|WP_046375586.1\|721949_722945_+\|GHMP-kinase	unknown	unknown	gnl\|CDD\|224493
NZ_CP010429.1\|WP_046375574.1\|710463_713472_-\|serine-hydrolase	unknown	unknown	gnl\|CDD\|366376
NZ_CP010429.1\|WP_046375573.1\|709996_710464_-\|damage-inducible-protein-DinB	unknown	unknown	gnl\|CDD\|225200
NZ_CP010429.1\|WP_046375583.1\|719928_720567_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046375589.1\|728818_730588_-\|aspartate--tRNA-ligase	unknown	unknown	gnl\|CDD\|234775
NZ_CP010429.1\|WP_046375575.1\|713575_714256_-\|PorT-family-protein	unknown	unknown	gnl\|CDD\|372635
NZ_CP010429.1\|WP_046375587.1\|723025_723889_+\|UTP--glucose-1-phosphate-uridylyltransferase-GalU	unknown	unknown	gnl\|CDD\|224131
NZ_CP010429.1\|WP_046375579.1\|715980_716310_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|237030
NZ_CP010429.1\|WP_046578970.1\|716370_717564_-\|DUF748-domain-containing-protein	unknown	unknown	gnl\|CDD\|377502
NZ_CP010429.1\|WP_046375582.1\|719103_719892_-\|PD-(D/E)XK-nuclease-like-domain-containing-protein	unknown	unknown	gnl\|CDD\|378917
NZ_CP010429.1\|WP_046375578.1\|715657_715936_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046375584.1\|720822_721185_+\|transcriptional-regulator	unknown	unknown	gnl\|CDD\|237361
NZ_CP010429.1\|WP_046375577.1\|714867_715470_-\|sigma-70-family-RNA-polymerase-sigma-factor	unknown	unknown	gnl\|CDD\|274357
NZ_CP010429.1\|WP_046375572.1\|709439_709970_-\|DUF4468-domain-containing-protein	unknown	unknown	gnl\|CDD\|379681
NZ_CP010429.1\|WP_046375581.1\|718659_719007_-\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP010429.1\|WP_082111497.1\|727101_728691_+\|sulfatase	gnl\|CDD\|293751	cd16027, SGSH, N-sulfoglucosamine sulfohydrolase (SGSH; sulfamidase). N-sulfoglucosamine sulfohydrolase (SGSH) belongs to the sulfatase family and catalyses the cleavage of N-linked sulfate groups from the GAGs heparin sulfate and heparin. The active site is characterized by the amino-acid sequence motif C(X)PSR that is highly conserved among most sulfatases. The cysteine residue is post-translationally converted to a formylglycine (FGly) residue, which is crucial for the catalytic process. Loss of function of SGSH results a disease called mucopolysaccharidosis type IIIA (Sanfilippo A syndrome), a fatal childhood-onset neurodegenerative disease with mild facial, visceral and skeletal abnormalities.	1.26599e-157
NZ_CP010429.1\|WP_046375571.1\|708622_709285_+\|endonuclease-III	gnl\|CDD\|223255	COG0177, Nth, Predicted EndoIII-related endonuclease [DNA replication, recombination, and repair].	3.57775e-56
NZ_CP010429.1\|WP_046375574.1\|710463_713472_-\|serine-hydrolase	gnl\|CDD\|366376	pfam00933, Glyco_hydro_3, Glycosyl hydrolase family 3 N terminal domain.	6.05372e-77
NZ_CP010429.1\|WP_046375584.1\|720822_721185_+\|transcriptional-regulator	gnl\|CDD\|237361	PRK13355, PRK13355, bifunctional HTH-domain containing protein/aminotransferase; Provisional.	0.000169791
NZ_CP010429.1\|WP_046375589.1\|728818_730588_-\|aspartate--tRNA-ligase	gnl\|CDD\|234775	PRK00476, aspS, aspartyl-tRNA synthetase; Validated.	0
NZ_CP010429.1\|WP_046375575.1\|713575_714256_-\|PorT-family-protein	gnl\|CDD\|372635	pfam13568, OMP_b-brl_2, Outer membrane protein beta-barrel domain. This domain is found in a wide range of outer membrane proteins. This domain assumes a membrane bound beta-barrel fold.	4.63659e-16
NZ_CP010429.1\|WP_046375587.1\|723025_723889_+\|UTP--glucose-1-phosphate-uridylyltransferase-GalU	gnl\|CDD\|224131	COG1210, GalU, UDP-glucose pyrophosphorylase [Cell envelope biogenesis, outer membrane].	2.68528e-163
NZ_CP010429.1\|WP_046375579.1\|715980_716310_+\|hypothetical-protein	gnl\|CDD\|237030	PRK12270, kgd, multifunctional oxoglutarate decarboxylase/oxoglutarate dehydrogenase thiamine pyrophosphate-binding subunit/dihydrolipoyllysine-residue succinyltransferase subunit.	0.00908027
NZ_CP010429.1\|WP_046578970.1\|716370_717564_-\|DUF748-domain-containing-protein	gnl\|CDD\|377502	pfam05359, DUF748, Domain of Unknown Function (DUF748).	5.96725e-12
NZ_CP010429.1\|WP_046375582.1\|719103_719892_-\|PD-(D/E)XK-nuclease-like-domain-containing-protein	gnl\|CDD\|378917	pfam12684, DUF3799, PDDEXK-like domain of unknown function (DUF3799). This family of proteins is functionally uncharacterized. This family of proteins is found in bacteria and viruses. Proteins in this family are typically between 265 and 420 amino acids in length. It appears that these proteins are distantly related to the PDDEXK superfamily and so these domains are likely to be nucleases. This family has a C-terminal cysteine cluster similar to that found in pfam01930.	1.64415e-14
NZ_CP010429.1\|WP_046375573.1\|709996_710464_-\|damage-inducible-protein-DinB	gnl\|CDD\|225200	COG2318, DinB, Uncharacterized protein conserved in bacteria [Function unknown].	2.40226e-13
NZ_CP010429.1\|WP_046375586.1\|721949_722945_+\|GHMP-kinase	gnl\|CDD\|224493	COG1577, ERG12, Mevalonate kinase [Lipid metabolism].	1.98757e-18
NZ_CP010429.1\|WP_046375577.1\|714867_715470_-\|sigma-70-family-RNA-polymerase-sigma-factor	gnl\|CDD\|274357	TIGR02937, RNA_polymerase_sigma_factor, RNA polymerase sigma factor, sigma-70 family. This model encompasses all varieties of the sigma-70 type sigma factors including the ECF subfamily. A number of sigma factors have names with a different number than 70 (i.e. sigma-38), but in fact, all except for the Sigma-54 family (TIGR02395) are included within this family. Several Pfam models hit segments of these sequences including Sigma-70 region 2 (pfam04542) and Sigma-70, region 4 (pfam04545), but not always above their respective trusted cutoffs.	1.62261e-25
NZ_CP010429.1\|WP_046375572.1\|709439_709970_-\|DUF4468-domain-containing-protein	gnl\|CDD\|379681	pfam14730, DUF4468, Domain of unknown function (DUF4468) with TBP-like fold. A large family of (predicted) secreted proteins with unknown functions from human gut and oral cavity. Typically forms a N-terminal domain with FMN binding domain at the C-terminus. Experimentaly determined 3D structure of this domain shows a variant of a TATA box binding - like fold, but no detectable sequence similarity to other proteins with this fold.	5.92996e-08
NZ_CP010429.1\|WP_148562533.1\|723938_726821_-\|DUF11-domain-containing-protein	gnl\|CDD\|307488	pfam01345, DUF11, Domain of unknown function DUF11. A domain of unknown function found in multiple copies in several archaebacterial proteins. Conserved N-terminal lysine and C-terminal asparagine with central asp/glu suggests that many of these domain may contain an isopeptide bond.	1.85322e-09

>NZ_CP010429.1|WP_046578970.1|716370_717564_-|DUF748-domain-containing-protein
MKRTTKIILALVVLLIIARLLLPYFVLRYVNKTLADMGSYTGHVDDIDIQLIRGAYQLDNLNIRKINGKLKEPFVFIPKTDLSVEWKSLFKGKLVSEVECYEPKINFAFSDTESSNQTGADVDWTVYLKKLLPISINRFAVINGKVNLTSLVTQPRADLSIQKFQGEIRNIRNVEDKNNKLPSPVEASGDVPGYGGTMNFYANMNLLKEVPDFDYKLRFSDLQLVKLNPLARHYANLDFERGTVSVYSEMAMLNSKLNGYLKPLTKGMQIFKLDEHEGRSIGKFFTELVAQAGTAIFKNQKRDQVATRIPLNGTIDDIKTATWPTIFGVLRNAYIEAFKGEFDNNITLQDAVKSFKDDFKAKRAERKAERKEKRAERKAERQAKRAKRKAEKKEKKK
>NZ_CP010429.1|WP_046375579.1|715980_716310_+|hypothetical-protein
MIKVLLGVLLMATPALAQTTPQTAKTSAPKSASGSASSAKPTSASASARSKKPIPPPSMKDNLESKDNAIPTYKKEKDAGVQKVRYRYQPRRTESGARKDTLIDRRKSQ
>NZ_CP010429.1|WP_046375578.1|715657_715936_+|hypothetical-protein
MKRFSFSLLGLLVSISALAQSNQAPTMQQSTSTTDTRQANPVRPKIKPANRQERLKMEAGVDSTLPKNRKQKRLRPDSLRRGGATKVDSVRR
>NZ_CP010429.1|WP_046375577.1|714867_715470_-|sigma-70-family-RNA-polymerase-sigma-factor
MFLKLFRKPRASSGHSRKEPADYIAAYRATGDLAVLGELYEQHMDLVYAVCFNYLRDEDEAKDAVMNLFEQLVTDLRKHDVQQFGPWLHSVARNYCLMQLRKMQAHPKAALVTGTGADLDDEPIMQLSADDADKSELEEDLTTMEACLKTLPHEQQTCLTLFYLDHKTYTEVAELTGYDLKQVKSYLQNGRRNLKICMRK
>NZ_CP010429.1|WP_046375576.1|714396_714813_-|hypothetical-protein
MNDQLSFTDLQAYQAGQLSGPARYRVERLLLENPFYADALAGLEAMQQTAADAATRPTTEQLADLRDALHERIHASANQKRLWPLWIATTTAAILFMLAMAIYFIFFAPKQPVKPVLKPTTTVMTRPLSSTPLGMMKT
>NZ_CP010429.1|WP_046375575.1|713575_714256_-|PorT-family-protein
MFRANSLRFTIFSFLLVTSCLSSSFGQQRFSAGPRVGLNLSTFGMDAKDYTLRPGVTAGAFLMYSSLNHFGISGDVLYSQMGAKYADPANSQANSFKQRINYLEVPIALRYFLTLSGNFRPNVFFGPSFGFKLNAKRTNYIAQGVAQPDFDNSAEFRSMDLGLIAGFQLNFKGLGERQRFLIDARYRYGLSDITLNNNQNVNNSTITLTLGYGFGVGPEHPSRYRK
>NZ_CP010429.1|WP_046375574.1|710463_713472_-|serine-hydrolase
MPFCRSVLFGLFSVLLSFSTFAQTTPSTFLKLNARQSCWADSVFTNMAPDDRIAQLIMVAGYSNRRPAYEDSLITLVRTNKLGGVVMFQGGPVRQATLTNRLQANSPVPLLIAMDAEWGIAMRLDSTVRYPYQMTLGAMQGAGSDSLIYQMGANLAKQARRLGMHVNFAPSVDVNNNPNNPVINFRSFGEDKYAVARKALAYMRGMQDNQLLTSLKHFPGHGDTGTDSHYDLPLISKSRAQLDSLELYPFRELIKAGATGVMIAHLSIPSLDTTRNRPSTLSPAIVTNLLKNELGFRGLVFSDAMNMKGVTKFYPSGKADELGMEAGMDVLEFTEDVPSALAQVKQAIADGRISQASIDARCLKVLQAKAWAGLDQYKPVVLDNLVNDLNSVQDELLNRRLTEKSLTVLKNDQNIVPLQRLDTLRIASVAIESDKVTAFQQMAANYTKVDHFNLTSRTPDSTLAQIRDSLQNYNLILVDVHLNSIRPAVKYGLQSKTAGILSELVATGKAIVTVFGNVYALDKLTFPADTAQPGRTVEKARAIIMPYQLTNFTEELSAQLIFGAIGASGKLPVTVNQRFRLGDGITVQPIGRLKYTIPEEVGIDSRFLTQQVDSLVNVGLTQGAFPGCVVQMARNGKVIFRKAYGKHTYDASLGAEPRPVQLDDLYDMASVTKVSTSTPALMHLVDDKKFNLDGKMADYLPSFKKSNKADLRWRDVLTHQAGLKAFIPFWMDTKNPDGSWKPKTFKNERSARYPIEVTDSLFEFKSYPKTIFEQIRDSPLNAKKEYVYSDLSFILYPQIVKRLTGENFEDYLKTTFYKPLGATTLTFLPRRFYSLDRIVPTEYDSLFRKTLIWGRVHDEGAAMLNGLSGHAGLFGNANDLMKVYEMYRQKGSYAGQQYISAKTIAEFTRYQFPELGNRRGLGFDKPSFTYTGNAPRSATKASYGHSGYTGTFVWVEPDPAYNLTYIFLCNRVYPTRNNPKLGNLNTRTNIVEALYQATKRGL
>NZ_CP010429.1|WP_046375573.1|709996_710464_-|damage-inducible-protein-DinB
MKNYLIQLLDYELWANRRIIDALEKIDNPPARALALMGHILSAQHVWYGRIMHESTFITIWENIPVSWMGETAERQHRQLASHVLALKESEWLEQMEYVNTKEVAYKSSLLDILTHLSHHAAYHRGQIVQLIRPMVKEAPVTDFIIWKREEKVAK
>NZ_CP010429.1|WP_046375572.1|709439_709970_-|DUF4468-domain-containing-protein
MKYLFILFLFVSISALAQVKLPTNEVGQVQYQELVRVPDSKRTARQLMEQVHSWATRYYPLGNEAEQQYDREHNILFVRTFYSIGNQSVRYTLTIETKFGRYRATITDLIIDDNGRTQPVRAVTSTVDELAVAADSTVKDKRVIEQIAADQAELYRQIDKACRETLANLKQSLTEN
>NZ_CP010429.1|WP_046375571.1|708622_709285_+|endonuclease-III
MKPTFDLNVVLAHIDEAIRPYPKAAMFDLFEQGYNTLFEQLMSCIVSIRTLDETTIPVSLRLFEQARTPQQLLKLDVPTLTQLLYGTTYPDQKAYTMLGIAERIVNEFGGELPASYDTLTSLKGVGPKCANLALGVATGMAAISVDVHVHRVVNRWGYVHTKQPEQTLKVLETQVPRDQWVNINRLLMPFGKHICTGTLPHCSTCPVLPWCEQVGVDRHR
>NZ_CP010429.1|WP_046375581.1|718659_719007_-|hypothetical-protein
MNASIITLTPTDLHFDWGTDGLVLWIEELDGADSLAGQMSEVMDRIAFAIELQTGWDHRTDADTLHPLYGYRLLLRDASGLWNAVQTDETGHFAGLIALEELDYEVAYDKVMWLD
>NZ_CP010429.1|WP_046375582.1|719103_719892_-|PD-(D/E)XK-nuclease-like-domain-containing-protein
MISQLLTPFSQPLIMPGDDYRALPRVSNSDLTRLKEEHLGYWSVPSARFIPEKTKAFGRAFHQHLLEPETVGTVLSQFLPDMMDPALRPDGLAPAQTKQLHTLMQTIRQDGFCRRYLRLSERERIVLSTEPTTGIACKARLDMVYTSPKRRNAMVIDLKTTSARTQAQFLESCYTYDYDRQAAFYVDSLRHADGREWSTTKQFRFVFIGIMKQSPYRLFAVDATSIPGFIDYGRKKYRFWLRKWRDEQTAETLAAPAWSMSA
>NZ_CP010429.1|WP_046375583.1|719928_720567_-|hypothetical-protein
MNTQNKSQIETIQSGNELKPYQKIHELTGEVVNKYKYLEGHPRQYRFDAKEGVFNINGSEKLGRTLTFQPIAWRIFTDNILNMGTKNWAEIFFIDEKNCVSAVLFHGYSVDNIFRLIEPLYYDDLTLADVVITAVAEKKENNKIQPKGVYYIANFTYKMADVEKTKELKQFAQEVKVFRQETLTDIANIKTAMNYYNPFINPVEEPALLAAG
>NZ_CP010429.1|WP_046375584.1|720822_721185_+|transcriptional-regulator
MTINLRLQQLIDSLDISVLEFARQLGEHRGEKVYHILHGRLKPRYDTLEKILAAYPQVNGDWLLRGEGLMFKALNSPSAAITTEERLRNMEFLLFQLTERVALLQQTNDQLLAEIKGQRE
>NZ_CP010429.1|WP_046375585.1|721308_721794_+|hypothetical-protein
MATTSPFDPDKLDPEFYSRDPNQHGDSDYGRESEGVGNNSYRDATSGLDMETENLNITKDTRVAHEGEGRVGEPKGESLGGTQEWDVDADAISDQPKGRMMSDEAARKLGEVAENPSDDALLHRSDATYLEEGDRPGEGYDPHNVGYDGKEKTDVSKEDTH
>NZ_CP010429.1|WP_046375586.1|721949_722945_+|GHMP-kinase
MLIETRAYARAGLLGNPSDGFFGKTIAISVRNFGASVTLYPSPELHIEPQLQDTNVFRSLYHLRDSVSTLGYHGGVPLLKAAIKKFSEYCEAEHIRLPNQNFSIRYNTSIPRQVGLSGSSAIIVATFRALMQFYGVEIPQPILPNLVLATEAEELGITAGLQDRVIQCYEGCVYMDFDRDIMERQGYGQYEPLDSRLLPKLYIAYNTDLGKQSGRVHNDVRARWLKGEPVVVETMSAIADVAREGREAMLRQDGKALNELVNRNFDLRAQIYNITDRNRSLIEAARVCGASASFTGSGGSIIGLYRDDAMLNRLFVELKKINARVIKPYVV
>NZ_CP010429.1|WP_046375587.1|723025_723889_+|UTP--glucose-1-phosphate-uridylyltransferase-GalU
MIKKAVIPAAGLGTRFLPATKAQPKEMLPIIDRPTIQYVVQEAVDSGIEDILIITGKGKRAIEDHFDRNYELETRLEEKEDQLLLDEMRRLSDMANLHYVRQRELNGLGDAIRYARHHVGNEPFAVLLGDTIMDSVIPVTQQLIDTYAQFGGSVIAVEEVPHDKVNRYGIVGGKSLSDRIFELDTLVEKPSISEAPSNLAIAGRYILTPEIFAMLEQTPVGKNNEIQLTDAMLLLLKRENLYAHRIEGKRHDIGNKLDFLKTTVEFALKRPEFAGPFRAFLEEIIKK
>NZ_CP010429.1|WP_148562533.1|723938_726821_-|DUF11-domain-containing-protein
MVFQRNLANEAVVTVTGMASPTATTVEARFVPLASGQGAVTAWTPLNFLTGSKAFRGKVTVAAGWYRLDVRSKVGTTILTQTKVNRVGVGEVFVIAGQSNAFGGIERGLVAAEDRVMCVDFRQDSLSEQLLPLQFSHINYGSNMGPSQPPHMYGLLGDKLVQRLNVPVLFIGAALGGTSSTEWRQSAAGIIGTTPNPSVYRRLGAVLLHYIARTGARAVLWHQGESDINSSTQTYFDNIKYVIEKSRQQVGSKPLAWVISRASYISGQTNPQVINAQNQLINNVANVFAGPATDNIIGLDNRPDDIHFKGIGRLRFTEAWDASLTASFFQNSVPFMPTDSAVQITSGYTLPLTRRPGEIIAVASLRSDPHESDNKYVAQIVRVSDGATVFESDPSTDNPILITLPFTLQNGQYRLRTRSTHPVVLGTLGEPFNVQQDASPSIAFPIYRQPIIVGTADSVIRRFGYRYEKGATTFWGLIQATAPVEVKLESLFSNPFINSNWLVVPPSSQAPDFDAFSDFNYIQNYPAAQAGVSGVVPGRYRFSVRRQGDTGPGISFEMELLDGRQILYYPMEPIGAIPPVLTIGSSLNSSCLSGSFNVAVDVTDSVMNSGNVFSVRLSDASGSFANETTIGSSTTSPITATLSPSLPAGTNYRIRVVGSNPNVASAPSQSLSICPGGADLSMSMSVSNRTPAPNQPVTITLVITNSGPADAANVRAQSLLPTGMSFIGATSAATSASANTVSINVGTVPNGVSKPFIFRVKPIQQGTFATSAQITASAQRDPDSQPNSGTGDGQDDEATVDFRTPSASGPILASDNSNQVPLPPLQPNQPPTDPAKADLSLGLSASNLVVSTNQVISVSLVVSNLGGANATNVNVQTLLPTGWQLTVTTGLTINGQTVTASVGSIPAGRSTTMILYVRVPSLGTVRSQVFSASPTDPDSTPGNGYTKGEDDEAALSVRMR
>NZ_CP010429.1|WP_082111497.1|727101_728691_+|sulfatase
MISKIKYTYKFFAFTAGFVGRFGLLFFLCGVWALSGSPIRTKPSAKAIGTNSLQAEPRPNIVLIVSDDHGREALGCYGSLGAESPTVRTPHIDQLAADGTRFSNAFCTTASCSPSRSVLLTGLHNHANGMYGLEHQEHHFSSFDTVRSLPVLLEQAGYRTARIGKLHVAPERVYHFQQVLKAGGVNDPVSIGRSPVEMARLCYPFLDKNSAQSANPSVAQPFFLYFATDDPHRSNAVAADGSPIFDGSKPNLFGNRPGGYPQVGDHFYQPRQVRVPPYLPDTKACRAELAQYYESISRLDAGVGRLIDYLKDTGQYDNTLIVYLSDNGAPFPGAKTTLYEPGMRLPCIIKLPKPQKPGFVQDAMISWVDVTPTLLDFAGVGTSSLGKQGRSFRKIIEQENVSGWDEVYASHSLHEITMYYPMRVVRERRYKLIVNLAHQLPYPMALDLYNSFTWQDALRTKRKLFGKRTVAAYLHRPAVELYDLQTDPDEVKNLAANPRYQNVLVRLQAKLKHFQQQTRDPWLYKETRE
>NZ_CP010429.1|WP_046375589.1|728818_730588_-|aspartate--tRNA-ligase
MLRTHTCGELRLTDDNTTATLCGWVQTIRDKGGVLWIDLRDRYGITQLLLEDGQTAPELFTTARSLGREFVVKATGTVIERKSKNPNIPTGDIELKVTSLEVLNPAKLPPFLIEDETDGGDDLRMKYRYLDLRRNPVRRSLELRHRMAQQTRVYMDGQNFIEVETPVLIKSTPEGARDFVVPSRMNPGEFYALPQSPQTFKQLLMVSGFDRYYQIVKCFRDEDLRADRQPEFTQIDCEMSFVEQEDILNMFEGLVRHLFKAVKGIDMATVPRMTYADAMKFYGSDKPDTRFGMEFVELKGTFDTVDMTSGKGFGVFDSAELVVGINVPGCAHYTRKQLDELTDWIKRPQIGAKGLIYVRYNEDGTLKSSVDKFYSEADLKGWAAHFGAKPGDLMLILSGDAAKARKQLSELRLEMGSRLGLRDPNVFSTLWVLDFPLLEYGEEEQRWFAMHHPFTSPKPEDIPLLDTDLGAVRANAYDLVINGTEVGGGSIRIFNRDLQARMFSILGFSDEEAKAQFGFLMDAFEFGAPPHGGIAFGFDRLCSLFGGADSIRDFIAFPKNNSGRDVMIDSPSPISQAQLNELKIATVAK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010429_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010429_3

1472362-1475569

TypeI-B

Consensus_repeat	Method
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CRISPRCasFinder
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGNNNNN	CRT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	PILER-CR

43 spacers

cas4,cas2,cas1,cas6,cas3,cas5,cas7b,cas8b1

The CRISPR arrays of NZ_CP010429_3

>merge|NZ_CP010429|3|1472362-1475569|CRISPRCasFinder,CRT,PILER-CR
TTTCAGTTTCAATCCTTCGTGGATTAGCCTCTGGAAGCCGGTGGTGTTACGGGCTTTGGGGGCGTAGGATTCATGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCAGATTTTCCACTACCGGGACGGCCCGATATAACCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTTTTACTGTAGGTCGGGCTGGGTGGATTGACAAAGTCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGACCGGCGTGTCAATTTCGGCCTAACGCGCTTTATGATGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAAAGCCTGCATCTGACGGATGGTAACTCTGTCACGGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAGTTGAACAGGTTGCCGCAGTCCTCGTCCGTTATGGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAAACAGAAGTCTTAATAATGTGATGCAGGCTTATTCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTTCGTAATACCCGCCCTCAGCATCGGAGGTACCCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAAACAGAAGTCTTAATAATGTGATGCAGGCTTATTCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTTCGTAATACCCGCCCTCAGCATCGGAGGTACCCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCGTAGTATCGAAAGGATACAAAGGCAATCAAGATGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAATAGTCTGTTCGCCTGTGAATAGTCCACCTTTTTGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTGCATGAAGTATCACAGTACGGGGCACAACACGTTCAGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTTCCCGGTTGATTACCGGTTGATCCGTCTGGTCGAAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGGTTATATCAACGCCCGTATTGTCATATTGACGGGCAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGACTCAGGCAAGGGCTTATCCGGTAACGTGGCGACGTGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGCCCCAGATAGCAGGCCATAGCCGCTCCAGACAATACCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGATTTGGGGGGCATCGGTCCGCGTCCAGCTTGTGCCGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGCCTGGAGGATATACAGCCGCTGTTGCATCCGGGTGTGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGACTGCATTAGGCGTTGAGGTGAAAGCGCTATTTGAAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGTGTAGTTTTCAATGCTGACGATTTCGCCAAATGTGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGGCAACCCATTCGACCAGTTCCTGAAGCTTGTAGGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCATTGAACAACGCCTGGTTGAAATCCTCGTCAAGTGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGGTCTACCGTTCCGCCACCCGGCCGCGTCAGGTAAAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGACATGACTTCATTATTCATGTTAATACTTTACAGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAATCCCACGGCTTTCTGTAATTTTTCAGACATGCCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGACATCGTTAACTACATCGTTAAGAAGTCGCTACGGGCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGATCACAGAATATTATTTGTGGGAAGGATCAGGATTGGAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGCGGGAAATCGTGGAGCAGAGCGCGGCCTGTTTGCCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAGACTACGCGTTATTTTATCGAAAGAGCCGATCAAAGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGCCGATACAGATAACCCCGAAGCCGTAACGAAGGGCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGCGCTAAACTGCTCATCGTTGAATTGCGTGTAATGCGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTGGCTAACGGGTATATCTTCGACTAACTCGACTAATCCGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGAACAGGCTTTAGAAGCCAATAAACAGGCCGTTAACCGGGTAGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTCAACAATAGCAACGTTTACAACGGCTATATGTACGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGAATGAATGAATTGCGTAACACAACGCAAATTCCAGAAGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGTACCGATGCTGAACGTATCGCGGGCAAGGTTATCAAGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGGTATTCGAAACGCTCATACCTAACGGTACGATAGGGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAGGAGCTACTTCAGTTAACTGAGTACAATTACCAGGAAGGTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG

>NZ_CP010429|3|3|1472362-1475569|CRISPRCasFinder
TTTCAGTTTCAATCCTTCGTGGATTAGCCTCTGGAAG	CCGGTGGTGTTACGGGCTTTGGGGGCGTAGGATTCAT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAGATTTTCCACTACCGGGACGGCCCGATATAACCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTTTACTGTAGGTCGGGCTGGGTGGATTGACAAAGTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACCGGCGTGTCAATTTCGGCCTAACGCGCTTTATGAT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAAGCCTGCATCTGACGGATGGTAACTCTGTCACGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGTTGAACAGGTTGCCGCAGTCCTCGTCCGTTATGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCGTAGTATCGAAAGGATACAAAGGCAATCAAGATGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATAGTCTGTTCGCCTGTGAATAGTCCACCTTTTT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGCATGAAGTATCACAGTACGGGGCACAACACGTTCAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCCCGGTTGATTACCGGTTGATCCGTCTGGTCGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTTATATCAACGCCCGTATTGTCATATTGACGGGCA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTCAGGCAAGGGCTTATCCGGTAACGTGGCGACGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCCCAGATAGCAGGCCATAGCCGCTCCAGACAATACC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATTTGGGGGGCATCGGTCCGCGTCCAGCTTGTGCCGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCTGGAGGATATACAGCCGCTGTTGCATCCGGGTGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTGCATTAGGCGTTGAGGTGAAAGCGCTATTTGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GTGTAGTTTTCAATGCTGACGATTTCGCCAAATGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGCAACCCATTCGACCAGTTCCTGAAGCTTGTAGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCATTGAACAACGCCTGGTTGAAATCCTCGTCAAGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTCTACCGTTCCGCCACCCGGCCGCGTCAGGTAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GACATGACTTCATTATTCATGTTAATACTTTACAGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATCCCACGGCTTTCTGTAATTTTTCAGACATGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACATCGTTAACTACATCGTTAAGAAGTCGCTACGGGC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATCACAGAATATTATTTGTGGGAAGGATCAGGATTGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CGGGAAATCGTGGAGCAGAGCGCGGCCTGTTTGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGACTACGCGTTATTTTATCGAAAGAGCCGATCAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCGATACAGATAACCCCGAAGCCGTAACGAAGGGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCGCTAAACTGCTCATCGTTGAATTGCGTGTAATGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGGCTAACGGGTATATCTTCGACTAACTCGACTAATCC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAACAGGCTTTAGAAGCCAATAAACAGGCCGTTAACCGGGTAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAACAATAGCAACGTTTACAACGGCTATATGTACG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATGAATGAATTGCGTAACACAACGCAAATTCCAGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TACCGATGCTGAACGTATCGCGGGCAAGGTTATCAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTATTCGAAACGCTCATACCTAACGGTACGATAGGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAGCTACTTCAGTTAACTGAGTACAATTACCAGGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG

>NZ_CP010429|3|1|1472367-1475569|CRT
GTTTCAATCCTTCGTGGATTAGCCTCTGGAAGCCGGT	GGTGTTACGGGCTTTGGGGGCGTAGGATTCAT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAGATTTTCCACTACCGGGACGGCCCGATATAACCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTTTACTGTAGGTCGGGCTGGGTGGATTGACAAAGTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACCGGCGTGTCAATTTCGGCCTAACGCGCTTTATGAT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAAGCCTGCATCTGACGGATGGTAACTCTGTCACGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGTTGAACAGGTTGCCGCAGTCCTCGTCCGTTATGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCGTAGTATCGAAAGGATACAAAGGCAATCAAGATGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATAGTCTGTTCGCCTGTGAATAGTCCACCTTTTT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGCATGAAGTATCACAGTACGGGGCACAACACGTTCAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCCCGGTTGATTACCGGTTGATCCGTCTGGTCGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTTATATCAACGCCCGTATTGTCATATTGACGGGCA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTCAGGCAAGGGCTTATCCGGTAACGTGGCGACGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCCCAGATAGCAGGCCATAGCCGCTCCAGACAATACC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATTTGGGGGGCATCGGTCCGCGTCCAGCTTGTGCCGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCTGGAGGATATACAGCCGCTGTTGCATCCGGGTGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTGCATTAGGCGTTGAGGTGAAAGCGCTATTTGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GTGTAGTTTTCAATGCTGACGATTTCGCCAAATGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGCAACCCATTCGACCAGTTCCTGAAGCTTGTAGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCATTGAACAACGCCTGGTTGAAATCCTCGTCAAGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTCTACCGTTCCGCCACCCGGCCGCGTCAGGTAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GACATGACTTCATTATTCATGTTAATACTTTACAGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATCCCACGGCTTTCTGTAATTTTTCAGACATGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACATCGTTAACTACATCGTTAAGAAGTCGCTACGGGC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATCACAGAATATTATTTGTGGGAAGGATCAGGATTGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CGGGAAATCGTGGAGCAGAGCGCGGCCTGTTTGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGACTACGCGTTATTTTATCGAAAGAGCCGATCAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCGATACAGATAACCCCGAAGCCGTAACGAAGGGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCGCTAAACTGCTCATCGTTGAATTGCGTGTAATGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGGCTAACGGGTATATCTTCGACTAACTCGACTAATCC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAACAGGCTTTAGAAGCCAATAAACAGGCCGTTAACCGGGTAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAACAATAGCAACGTTTACAACGGCTATATGTACG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATGAATGAATTGCGTAACACAACGCAAATTCCAGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TACCGATGCTGAACGTATCGCGGGCAAGGTTATCAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTATTCGAAACGCTCATACCTAACGGTACGATAGGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAGCTACTTCAGTTAACTGAGTACAATTACCAGGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG

>NZ_CP010429|3|1|1472436-1475569|PILER-CR
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAGATTTTCCACTACCGGGACGGCCCGATATAACCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTTTACTGTAGGTCGGGCTGGGTGGATTGACAAAGTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACCGGCGTGTCAATTTCGGCCTAACGCGCTTTATGAT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAAGCCTGCATCTGACGGATGGTAACTCTGTCACGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGTTGAACAGGTTGCCGCAGTCCTCGTCCGTTATGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCTGAGCCGGGCTTTCCTATCTACGATCATGGAAACTA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCCAAACCTTTTGTTTTGAATTACCCAAGTAGGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AAACAGAAGTCTTAATAATGTGATGCAGGCTTATTC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCGTAATACCCGCCCTCAGCATCGGAGGTACCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCGTAGTATCGAAAGGATACAAAGGCAATCAAGATGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATAGTCTGTTCGCCTGTGAATAGTCCACCTTTTT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGCATGAAGTATCACAGTACGGGGCACAACACGTTCAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TTCCCGGTTGATTACCGGTTGATCCGTCTGGTCGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTTATATCAACGCCCGTATTGTCATATTGACGGGCA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTCAGGCAAGGGCTTATCCGGTAACGTGGCGACGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCCCAGATAGCAGGCCATAGCCGCTCCAGACAATACC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATTTGGGGGGCATCGGTCCGCGTCCAGCTTGTGCCGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCTGGAGGATATACAGCCGCTGTTGCATCCGGGTGT
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACTGCATTAGGCGTTGAGGTGAAAGCGCTATTTGAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GTGTAGTTTTCAATGCTGACGATTTCGCCAAATGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGCAACCCATTCGACCAGTTCCTGAAGCTTGTAGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCATTGAACAACGCCTGGTTGAAATCCTCGTCAAGTGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTCTACCGTTCCGCCACCCGGCCGCGTCAGGTAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GACATGACTTCATTATTCATGTTAATACTTTACAGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATCCCACGGCTTTCTGTAATTTTTCAGACATGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ACATCGTTAACTACATCGTTAAGAAGTCGCTACGGGC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	ATCACAGAATATTATTTGTGGGAAGGATCAGGATTGGA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CGGGAAATCGTGGAGCAGAGCGCGGCCTGTTTGCCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AGACTACGCGTTATTTTATCGAAAGAGCCGATCAAA
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	CCGATACAGATAACCCCGAAGCCGTAACGAAGGGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GCGCTAAACTGCTCATCGTTGAATTGCGTGTAATGCG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TGGCTAACGGGTATATCTTCGACTAACTCGACTAATCC
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAACAGGCTTTAGAAGCCAATAAACAGGCCGTTAACCGGGTAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TCAACAATAGCAACGTTTACAACGGCTATATGTACG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	AATGAATGAATTGCGTAACACAACGCAAATTCCAGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	TACCGATGCTGAACGTATCGCGGGCAAGGTTATCAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GGTATTCGAAACGCTCATACCTAACGGTACGATAGGG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG	GAGCTACTTCAGTTAACTGAGTACAATTACCAGGAAG
GTTTCAATCCTTCTTCTCGTGGATTAGCCTCTGGAAG

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010429.1\|WP_046376076.1\|1477742_1478486_-\|CRISPR-associated-endonuclease-Cas6	cas6	cls000004_cas6_CAS-I:CAS-III	gnl\|CDD\|379957
NZ_CP010429.1\|WP_046376072.1\|1470450_1472145_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046376074.1\|1476355_1476646_-\|CRISPR-associated-endonuclease-Cas2	cas2	cd09725_cas2_CAS-I:CAS-II:CAS-III:CAS-V	gnl\|CDD\|187856
NZ_CP010429.1\|WP_148562383.1\|1464377_1470467_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|211749
NZ_CP010429.1\|WP_046376079.1\|1482600_1484520_-\|TIGR02556-family-CRISPR-associated-protein	cas8b1	cd09730_cas8b1_CAS-I-B	gnl\|CDD\|378190
NZ_CP010429.1\|WP_046376075.1\|1476642_1477689_-\|CRISPR-associated-endonuclease-Cas1	cas1	pfam01867_cas1_CAS-I:CAS-II:CAS-III	gnl\|CDD\|187766
NZ_CP010429.1\|WP_046376064.1\|1452472_1453750_+\|methionine-adenosyltransferase	unknown	unknown	gnl\|CDD\|235374
NZ_CP010429.1\|WP_046376080.1\|1484663_1485104_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_158500542.1\|1478485_1480903_-\|CRISPR-associated-helicase-Cas3'	cas3	COG1203_cas3_CAS-I	gnl\|CDD\|350688
NZ_CP010429.1\|WP_046376065.1\|1453838_1454216_-\|ribosome-associated-translation-inhibitor-RaiA	unknown	unknown	gnl\|CDD\|238308
NZ_CP010429.1\|WP_046376078.1\|1481702_1482596_-\|type-I-B-CRISPR-associated-protein-Cas7/Csh2	cas7b	pfam05107_cas7b_CAS-I-B:CAS-I-C	gnl\|CDD\|274217
NZ_CP010429.1\|WP_046376069.1\|1461041_1463159_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|238020
NZ_CP010429.1\|WP_046376073.1\|1475765_1476353_-\|CRISPR-associated-protein-Cas4	cas4	cd09637_cas4_CAS-I:CAS-II:CAS-V	gnl\|CDD\|187768
NZ_CP010429.1\|WP_046376070.1\|1463187_1464378_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_052731084.1\|1458201_1461039_-\|fibronectin-type-III-domain-containing-protein	unknown	unknown	gnl\|CDD\|238020
NZ_CP010429.1\|WP_046376081.1\|1485126_1485309_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046376067.1\|1456023_1457748_+\|GMC-family-oxidoreductase	unknown	unknown	gnl\|CDD\|225186
NZ_CP010429.1\|WP_052731085.1\|1480950_1481706_-\|type-I-B-CRISPR-associated-protein-Cas5	cas5	cls001430_cas5_CAS-I-B	gnl\|CDD\|131641
NZ_CP010429.1\|WP_046376068.1\|1457764_1458205_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046376066.1\|1454426_1455785_-\|cytochrome-P450	unknown	unknown	gnl\|CDD\|365848

Protein	Function_ID	Function_description	E-value
NZ_CP010429.1\|WP_046376074.1\|1476355_1476646_-\|CRISPR-associated-endonuclease-Cas2	gnl\|CDD\|187856	cd09725, Cas2_I_II_III, CRISPR/Cas system-associated protein Cas2. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas2 is present in majority of CRISPR/Cas systems along with Cas1; RNAse specific to U-rich regions; Possesses an RRM/ferredoxin fold.	4.5345e-21
NZ_CP010429.1\|WP_148562383.1\|1464377_1470467_-\|hypothetical-protein	gnl\|CDD\|211749	TIGR02542, T_forsyth_147, TANFOR domain. The longest predicted protein in Tannerella forsythia (Bacteroides forsythus) ATCC 43037 is over 3000 residues long and lacks homology to other known proteins. Immediately after the signal sequence are four tandem repeats, approximately 147 residues long. This model describes that repeat, plus homologous single copy N-terminal domains in other large bacterial proteins. We designate this region the TANFOR domain. Many proteins with this domain also have fibronectin type III domains.	1.77826e-08
NZ_CP010429.1\|WP_046376079.1\|1482600_1484520_-\|TIGR02556-family-CRISPR-associated-protein	gnl\|CDD\|378190	pfam09484, Cas_TM1802, CRISPR-associated protein TM1802 (cas_TM1802). Clusters of short DNA repeats with non-homologous spacers, which are found at regular intervals in the genomes of phylogenetically distinct prokaryotic species, comprise a family with recognisable features. This family is known as CRISPR (short for Clustered, Regularly Interspaced Short Palindromic Repeats). A number of protein families appear only in association with these repeats and are designated Cas (CRISPR-Associated) proteins. This minor cas protein is found in at least five prokaryotic genomes: Methanosarcina mazei, Sulfurihydrogenibium azorense, Thermotoga maritima, Carboxydothermus hydrogenoformans, and Dictyoglomus thermophilum, the first of which is archaeal while the rest are bacterial.	1.269e-72
NZ_CP010429.1\|WP_158500542.1\|1478485_1480903_-\|CRISPR-associated-helicase-Cas3'	gnl\|CDD\|350688	cd17930, DEXHc_cas3, DEXH/Q-box helicase domain of Cas3. CRISPR-associated (Cas) 3 is a nuclease-helicase responsible for degradation of dsDNA. The two enzymatic units of Cas3, a histidine-aspartate (HD) nuclease and a Superfamily 2 (SF2) helicase, may be expressed from separate genes as Cas3' (SF2 helicase) and Cas3'' (HD nuclease) or may be fused as a single HD-SF2 polypeptide. The nucleolytic activity of most Cas3 enzymes is transition metal ion-dependent. Cas3 is a member of the DEAD-like helicase superfamily, a diverse family of proteins involved in ATP-dependent RNA or DNA unwinding. This domain contains the ATP-binding region.	3.0512e-41
NZ_CP010429.1\|WP_046376065.1\|1453838_1454216_-\|ribosome-associated-translation-inhibitor-RaiA	gnl\|CDD\|238308	cd00552, RaiA, RaiA ("ribosome-associated inhibitor A", also known as Protein Y (PY), YfiA, and SpotY, is a stress-response protein that binds the ribosomal subunit interface and arrests translation by interfering with aminoacyl-tRNA binding to the ribosomal A site. RaiA is also thought to counteract miscoding at the A site thus reducing translation errors. The RaiA fold structurally resembles the double-stranded RNA-binding domain (dsRBD).	9.91757e-12
NZ_CP010429.1\|WP_052731085.1\|1480950_1481706_-\|type-I-B-CRISPR-associated-protein-Cas5	gnl\|CDD\|131641	TIGR02592, hypothetical_protein_CTC_01466, CRISPR-associated protein Cas5, subtype I-B/HMARI. This is a CRISPR-associated protein unique to the hmari subtype of cas genes and CRISPR repeat, which is the only subtype present in Haloarcula marismortui ATCC 43049. The hmari type, though uncommon, is also found in the Aquificae, Thermotogae, Firmicutes, and Dictyoglomi.	3.15824e-35
NZ_CP010429.1\|WP_046376064.1\|1452472_1453750_+\|methionine-adenosyltransferase	gnl\|CDD\|235374	PRK05250, PRK05250, S-adenosylmethionine synthetase; Validated.	0
NZ_CP010429.1\|WP_046376078.1\|1481702_1482596_-\|type-I-B-CRISPR-associated-protein-Cas7/Csh2	gnl\|CDD\|274217	TIGR02590, hypothetical_protein_MM_0563, CRISPR-associated protein Cas7/Csh2, subtype I-B/HMARI. This model represents one of two closely related CRISPR-associated proteins that belong to the larger family of TIGR01595. Members are the Csh2 protein of the Hmari subtype of CRISPR/cas system. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. The related model is TIGR02589, the Csd3 protein of the Dvulg CRISPR subtype.	2.70359e-74
NZ_CP010429.1\|WP_046376069.1\|1461041_1463159_-\|hypothetical-protein	gnl\|CDD\|238020	cd00063, FN3, Fibronectin type 3 domain; One of three types of internal repeats found in the plasma protein fibronectin. Its tenth fibronectin type III repeat contains an RGD cell recognition sequence in a flexible loop between 2 strands. Approximately 2% of all animal proteins contain the FN3 repeat; including extracellular and intracellular proteins, membrane spanning cytokine receptors, growth hormone receptors, tyrosine phosphatase receptors, and adhesion molecules. FN3-like domains are also found in bacterial glycosyl hydrolases.	0.000233916
NZ_CP010429.1\|WP_046376073.1\|1475765_1476353_-\|CRISPR-associated-protein-Cas4	gnl\|CDD\|187768	cd09637, Cas4_I-A_I-B_I-C_I-D_II-B, CRISPR/Cas system-associated protein Cas4. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas4 is RecB-like nuclease with three-cysteine C-terminal cluster.	1.07612e-24
NZ_CP010429.1\|WP_046376075.1\|1476642_1477689_-\|CRISPR-associated-endonuclease-Cas1	gnl\|CDD\|187766	cd09634, Cas1_I-II-III, CRISPR/Cas system-associated protein Cas1. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated Cas proteins comprise a system for heritable host defense by prokaryotic cells against phage and other foreign DNA; Cas1 is the most universal CRISPR system protein thought to be involved in spacer integration; Cas1 is metal-dependent deoxyribonuclease, also binds RNA; Shown to possess a unique fold consisting of a N-terminal beta-strand domain and a C-terminal alpha-helical domain.	1.23034e-88
NZ_CP010429.1\|WP_046376076.1\|1477742_1478486_-\|CRISPR-associated-endonuclease-Cas6	gnl\|CDD\|379957	pfam17262, DUF5328, Family of unknown function (DUF5328). This family of unknown function can be found in Bacteria and Archaea. Some of the proteins in this family are annotated in UniProt as putative DNA repair proteins.	3.61043e-43
NZ_CP010429.1\|WP_046376067.1\|1456023_1457748_+\|GMC-family-oxidoreductase	gnl\|CDD\|225186	COG2303, BetA, Choline dehydrogenase and related flavoproteins [Amino acid transport and metabolism].	8.9921e-66
NZ_CP010429.1\|WP_046376066.1\|1454426_1455785_-\|cytochrome-P450	gnl\|CDD\|365848	pfam00067, p450, Cytochrome P450. Cytochrome P450s are haem-thiolate proteins involved in the oxidative degradation of various compounds. They are particularly well known for their role in the degradation of environmental toxins and mutagens. They can be divided into 4 classes, according to the method by which electrons from NAD(P)H are delivered to the catalytic site. Sequence conservation is relatively low within the family - there are only 3 absolutely conserved residues - but their general topography and structural fold are highly conserved. The conserved core is composed of a coil termed the 'meander', a four-helix bundle, helices J and K, and two sets of beta-sheets. These constitute the haem-binding loop (with an absolutely conserved cysteine that serves as the 5th ligand for the haem iron), the proton-transfer groove and the absolutely conserved EXXR motif in helix K. While prokaryotic P450s are soluble proteins, most eukaryotic P450s are associated with microsomal membranes. their general enzymatic function is to catalyze regiospecific and stereospecific oxidation of non-activated hydrocarbons at physiological temperatures.	1.63534e-84
NZ_CP010429.1\|WP_052731084.1\|1458201_1461039_-\|fibronectin-type-III-domain-containing-protein	gnl\|CDD\|238020	cd00063, FN3, Fibronectin type 3 domain; One of three types of internal repeats found in the plasma protein fibronectin. Its tenth fibronectin type III repeat contains an RGD cell recognition sequence in a flexible loop between 2 strands. Approximately 2% of all animal proteins contain the FN3 repeat; including extracellular and intracellular proteins, membrane spanning cytokine receptors, growth hormone receptors, tyrosine phosphatase receptors, and adhesion molecules. FN3-like domains are also found in bacterial glycosyl hydrolases.	3.3138e-13

>NZ_CP010429.1|WP_046376072.1|1470450_1472145_-|hypothetical-protein
MRQCLLLFVYGFWLSCPAWAQTNPSAGKASPVKVSGGLNAYAGFYTASGIAARNQLSPFGLSGSVTVALPGGISLPFSAVLGNQGSSFRQPFNQFGVSPTYKWATVHAGYRNVSFSPFTLAGHTFLGGGVELNPGKLRLGAVYGRFNKAISTNLAEPDIVPAYGRTGYAVKVGYGKPANYVDLIMLRAKDDSASIVSAPQSVSQTVTPAENLVVGLTTRLLIVKHVTVELDGAVSAYTRDVRSSLVSAEGSNPVTRFFGRLITPRLATQLTQATQAAIGYRVQNAGIKLQYKRIDPNFQTMGAYYFQSDIESYAIAPNLTLMDGKLRLSGSYGIQYDNLANNKSARTGRKIGSLVVSYNPATAFGIDVQLSNYGISQQAGFRPLIDTIRLAQNNLSATINTRYTLQKEDVLQVFTLTTTYQKLSDLNATTASQTENNNINLNLGYFYQQTTTGWGFNGMLSYTQTQLPIAIGDTNRTVRFFGPTLGATQSFFEKKLTTSANASYLVNQQSGITGKVMTISINGGYQVTKRQTLNVSLNYLNSNTGLQEQTFNELRGNLGYGISF
>NZ_CP010429.1|WP_148562383.1|1464377_1470467_-|hypothetical-protein
MASLFKNFPLITALLVRKAATVLQRIRSVRLLCVLCAILCVFAVNPTQAQTFPLQIQVSVLPPYSAYLQDYPGAGQQVRVFLINTSRNTYQIRLAGQLTGDNGIEIRTSPNYRPPRPLTVPPGQTLLSRNDLEGLFDLNQIEVTGIDKNLLARGFPLPDGTYQLCVRAYNETPTNTAVTAFGQPLSAEFPLGCSAPIVVRSVEPPILISPLCDAEVTATTPQAVVFTWTPPAGVSPAQVDYTLRIVELPQTGVDPNVFIDAVALPKSGVEVRNLRTSTFLYGPTQPPLVVGKRYAWRVQAIDRSRKLNFLNDGKSPVCSFIYGTGLPVLAKKPGLELVQTPALPILPIPGLDAQDTPPAGATAIADKVPAPSTPYELKITNCNCKTPPSSTEGSVADNQAVLTKKQLTVAGFTVDLAGIQLDAEQKINGTGTVQLPYVGGGYIKLRVSLSKVQCNPAGQVIAGKVRGLLQQNASLLPGYDKPDFSALDLKPADVSEISKKLSAIKDQVKESITNSKNSIGWEMPLGVYTANVDVAITNVVFEPAQAYFDAVTWFKVASAQFGGVPLSATKVCMSPDKPICGDMTLYLGLDMPLSTLLTLKGATTDVNNKSANNLDFKKITNVNLNNWDFKTFHIVADLKPPGLKEANGINKDKELAVTLVYDSPKADLNDWTTTVEFPDFYVDKLSRDFIFSMDGKPGIYDQSELPDEYTAKLPNDYPQAGQKPGAEWKGLFFPKLNVTTTVLKSLNQGKPSTVSVENLIHDDNGFTGAFMATPVISLGDGSLDGWYCSADTLKLNLLMSQFKNARLAGRVVMPIFKYNPDEKQMEKGSIWPYTCTLSKDEKPNGGLTYQFQIVSPKEDVNVKLWAAKLSVLDGTNITVGNQGNKDGAFNASVTLNAKLSVDAKIVSPGMTILGMKLQSSPADGTSYFTSGTINSSFASPQKSLLAAADDEGFPVTIKSVSLDKVKGQASQYDFKFTGDITLMEGNIHAAITPYVRFKIGFGANKRPDWGLDKVGVDSVGIHGNLSFMRIDGTADFFDNEAPYGTGFRGDLNVKLLGAGFSVGGYFGRVNGFRYWQVGGKADLPAPVPIPGTPLTLAAFGGGAFHNMIKETQTDEKGKPKVGAPVKFTPSQKHDGFEVAVEVTMQSKDLFDMNGVMAATVSTENGFHLSDLRLDLDAALFGPEPDKALATGVGFIDVNFDKGYFDSKFGLNMHYGTTSGVFSVTGSGDMGLHVSFPSSLGNPDPKQDYSKEKPGDWYFFIGLPDATPCGNADDCFANSERIKLAIKVKSLGSLTFGSYFVMYHNLKPDGVTTLPPPPWGMSAADLEALGYKGVHLAGTDALAFGSGFVTDDKFEFGPFEAKFHAAFGFDLALQKITAPCSSGQIPGINGWYANGQMYADLALTLGINIDIWIYSGYLELLKVQAAALLEGGMVNPIWIHGSILLRYRALGGRIKGSTTFEMWYNKDEQCKPAFEQPNPFADLPIIAGLTPENNSKNVSVISPYYAEFSYPVRTLIQINDVDSLSRQPVASFRTFRLDFTSGTATNPFVTTQLQASSTNPNCSLDNSGRLRFGNDPDGGGNFNVTFFRDATLPPNAKLSVSLTVGVKLLNTGTNQYDPYYYKSQLVAETKSYTFTTGECVSSLSQEGAVPSVAYSYPFEGQRYFTIGDGGIFGYVELSSNFGCCLDKIQSDKYYRLSVRYTALKDNKFDKKDPGSVWTNNSAKFDGKLLRFGIPINFLQKKTLYRIEIFREPTDALVAEQKKIIAQQKGKIRKELEDTYLSGEKAEYGFGSAVTVSSKPGPGPGTGLMSNKVASVNGLAQGYNAAYVDQTVQKENSQQGNAIGAKVTGQSVGTMADIKLGKGKSDEEVDVKTQLEQPVYTYFFQTSQYNTLAEKLKASPFLAAEQKTVRTSDIEAYTIPIQSPEGFDSYELLWKKLPNGSVLPPLVLQKVLDSTNPWFADFVKPMVSLINGLSNYQLGNGNILFKTADNTAAPTVNYDQLMRQVVLFNQGGFDNAQTPISKNNLKGITQN
>NZ_CP010429.1|WP_046376070.1|1463187_1464378_-|hypothetical-protein
MKAKNLRRVYAIAGLLSLIGNLMNPSVCQAQYSMKMTQQDMTKAANTVITTDNADKKTASMALAGQAFASSPGKYGMMFLNVPVYKAYVERLEDNIDVLLSTLNGAYPQRKVLIDKLISLASSLTYAYQMAVGTQTGQPKSMSQAGREKFMKSISTSLNLDFYTEDFISLNDDYRNYFFSGRLQNAAVASGEVSITQYDPNMAYMSSQGSDPSRGKDRIRDTAKDCVALVLSVVKQTETVGAIGQAVSSVGSSVGAALGSSAASTGSVPNSAQVDKLFKTFTSVKGGNYWQLTKPGSVIGFYLKQLPGATLASDVTMKDGTGDRYVDKYAFENGLQPFPSSFALDLAKTVSNDFSGVGVVTVPGGTNGVIVVQPSSSSGNTSGQSSGTPAPPTPIH
>NZ_CP010429.1|WP_046376069.1|1461041_1463159_-|hypothetical-protein
MKVFVTLLILLFSMWGSGLRAQSTTTPTATRPSTQTTVAKSDTYFELSMIGRSFGDSVVVRWAPHNVILYREINRSGGYILTRRSLGANGRLQVDFQKDIKAWTLDEWKQRVSRTDSLAAACAQLIYGKSSVLQSANDPVTLDKLMQQKSQDDFQLMFLLLLADENVRHATGMGLGYVDRAVKKGVQYFYYLTPRYNGKLLSVDEQKVLVSNTGTYSRPPMPIVRAEQQDRAIKLSWDRQVTDELFSAYYIERSADGGRTFRRLNRLPYTQAPIQSEQALYSYVDSLKQNYVKYQYRVVGISPFAERSIPSPVLTAQGVDLTPPVGVRNVQAKHLGGSKVRITWEQPSLSPDFAGYVIARGNDESKPLIPLTKQVLGKTVREYVDETANPYEKTFYKVMAIDTAKNSNPSMAAYCTFKDVTGPAKPKNLQGYIDTTGFVRIVWDPNKEPDILGYAVLMANQADHVFTNRTSSYLPTSVFDDRTTLTTLTKKLYYRVVAYDKNYNPSPPSDILELARPDKVAPASPVISDYVASDTAIALRWVASISEDVREQILFRRGANTETWHQISKLTPKLNSYVDQQVKPNTPYSYMLVAVDSAGLRSAESFPLNTNTLQMAPRPAKQLSVQVGPDGKTIILSWKHPDQYARFIIYRSNEAKLLRSYDAVNREQTFTDKAIQKGQYEYAIKVVYQDGRESGLSNRVKIDIK
>NZ_CP010429.1|WP_052731084.1|1458201_1461039_-|fibronectin-type-III-domain-containing-protein
MKPHLPYLLLSLTMLVATRVFAQSNAPTGLTGTAPAYNRVVLTWKDNSTNETRFEIERNNFTSFTKIGEVGANVTTYTDNSVGGGTYRVRAVFVTGATALSNEFTISTPPEPPGIPTGLTVTPQNSNSIKLTWSNGSGSAPTDYRIERGTTSGGPFNLLQTVAYSRAPTFTDGSVSGGQPYCYRVRSQSGSVVSEFTAPVCTTPPLAPTNVKNLQANALSSSSIKLTWDRYGKESGIGIERRTGQSGDWRQVATTLADGGEFTDNNLNSNTEYCYRISESGHDYSSTACATTQQSAPRAPARLTATAVSSSQINLTWADLSDNEANFELQRADSPGAQFSTIQTLGPNTVTFSDQGLRASNQYCYRIRAVNSVGASEYTDSQCATTQAPPVGAPQNLVATATSTTQINLTWAGVSGATSYQLERSPNGNDGWTKVADPAGNAVSYDDPGLTPNTRYYYRIRALINGTPGPFSNVANALTPDVPPAAPARLVATAVSYNQINLTWADLSGNESGFQLERSPNGTDGWSKLADLGVDATNYEDKSVQPQTHYFYRVRAVNAAGPSANSNVADATTPVGPPVAAQDLKATAVSTTQISLTWSAIANAATILIERSPDGTTGWTSLTTVTGTATSYADNNLAVNTHYYYRIRATNASGQGPTSNVVDATTPDVPPAPPARLTATAVSPIQISLAWADLSGNESGFELERGARATGTFEKIADLPANTTSYEDKNLKDNQSYCYRVRAKNAAGPSAYTDAVCATTPLAPPANPTNLTAQVFDYDQIRLNWSALSSTAVTVVIERSNDPTSGFVEIKQQPANQTSYVDMGLQEFTTYYYRIRAVNTAGNSGYSNVASARIEEVIIAVEDELASHTTLYMNQRDLHIITNWYSSMRTTVQIMTATGQPVLTDTRKVNPADAWQYALDRLPTGIYIIAIVADGRSLTKRIVIP
>NZ_CP010429.1|WP_046376068.1|1457764_1458205_-|hypothetical-protein
MKNQLVLLFLLVSLGSCQPKPVKPITDLLGKVWKANTVKEADQLVFTLGATTNIKPGYINFRLDLSQPNKVNLKDVDGRLVTGTWSVSTDNKRLILDNLNPKPTNTGGLIEYYILSEPDGSSLQLERTSESRKTGNTIDQYALIPE
>NZ_CP010429.1|WP_046376067.1|1456023_1457748_+|GMC-family-oxidoreductase
MNITGDAKAARTYDAIVIGSGISGGWAAKELCEKGLKTLVLERGRDVKHIVDYPTATLNPWEFPHRNRMSDTFDKENPIATKCYALDEGTQQFFVKDAEHPYVQEKPFDWIRGYQVGGKSLIWARQTQRWSKFDFEANARDGAAIDWPIRYDDIAPWYSHVEKFVGISGNKDGLETLPDGEFLKPWQLNCVEKHIQKRVAESYQDRHVIIGRCAHLTEPKQIHYDQGRAQCQARHLCYRGCPYGGYFSSNSSTIPWAAKTGKLTLRPDSVVHSIMYEEGKAGKAGKATGVRVIDTHTKQMTEYYARIIFVNAACLNTNLILLNSTSRRFPNGLGNDSGVLGRYVAFHNYRGNIVADYEGFDDGYYYGRRPTTAFMPNFRNVRKQETDFQRGYMVAFSAARGNWQRGTGQDEFGADFKDKLSDPGAWHVFMMMQAETVPRYENQVRLSPDQKDPWGIPQLVTNIDYTDNDLKVMKDFLEQGAEMLDKSGCKHIKPYDDHRNPGLDIHEMGGVRMGRDPKTSLLNAHNQLHSVKNVFVTDGAAMTSTGTQNPSITFMALTARAVNFAVSEMKKTNL
>NZ_CP010429.1|WP_046376066.1|1454426_1455785_-|cytochrome-P450
METSTAPTQPVPLHPGLPFLGNTLAFLRNPLGTLDTLQRNHDRLVHLRIGGRHQYLVLQPEDAKHILQENHRNYGRSPAFDILKIFLGNGLLTSDGDFWRRQRRLAQPAFHRQKLAALTQTMISETADWIDELSGHNLKEPVNVSQAFMDVTMRIVCKTLFGSDTNGKLDGLSNALDTLNYLANNRMLSPLRFPYSWPTPNNQRSKRARMQVDSFIFGLIDERRKALDERDDLLGMLLSAEDEETGERMSNQQLRDESVTIFSAGHETTAVSMAWTIHLLTKHPDVLARLKAESQSVLGDARTPPPEAFRALTYTMQVVQESLRLYPPAWIMSRRAHQNDHVGPYTIPAGDTALVCPYLLHRDPANWPNPDRFDPERFAPGGLKDRLHSYAYLPFGGGPRLCIGNQFALMEMQILLALFVRRFTPKAAGNQRIVPKPLITLRPNQAIRAVLE
>NZ_CP010429.1|WP_046376065.1|1453838_1454216_-|ribosome-associated-translation-inhibitor-RaiA
MRLQINAVKFTADQSLLDFIQAKLDKLDTFHDHIIGGEVFLRLDGADSNKVKEKVVEVRLMLPGKELFVKEHDKSFESATDRVMDVLKDKLVRFKQKRNDISSPAIVEAQTQVETEDEVFEADEL
>NZ_CP010429.1|WP_046376064.1|1452472_1453750_+|methionine-adenosyltransferase
MPYLFTSESVSEGHPDKVADQISDALIDNFLAFDPSSKVACETLVTTGQVVLAGEIKTDTYLDVQKITRDVIRKIGYTKSEYMFEANSCGIFSALHDQSADINQGVDRKVENPDFETLANAQGAGDQGMMFGYATNETDNYMPLPLDLAHAILREMSQIRNNELELMPYLRPDAKSQVTIEYSDDDQPIRIDTIVVSTQHDDFADDETMLAKIKNDIINIVIPRVKAAQKAELHGLFTDNITYYINPTGKFVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNLVAAGLCDQVLVQVSYAIGVAKPCGLYVNTYGTSKVDMHDGEIAEKVAAIFDMRPYAIEQRLKLRNPIYSETAAYGHMGRKNEIVKKTFGSNGQTKEVEVELFTWEKLDFVDQVKAEFGL
>NZ_CP010429.1|WP_046376073.1|1475765_1476353_-|CRISPR-associated-protein-Cas4
MTLTPSHIIEHLFCPRFTYFEYVLAIPQYEEKNYKVMRGRNLHDERLERNKDYLRKRVGRPGAPVTEKHTDQYLTNELMRGVVDEVLGFGDGTMAPLDYKFAEYKDKVYETYRTQLYCYAWLIEVNFGRLVDRGFLVYTRSNNRVVEVPITEEDKLDVKQAAEAIFTIIDRNFYPKATKAKARCVTCTYRNICIK
>NZ_CP010429.1|WP_046376074.1|1476355_1476646_-|CRISPR-associated-endonuclease-Cas2
MIIWVLYDIGKDKARTKAAKRCQQAGLYRVQFSCFLGTLTQNQKDTLQLQLEELIDEETDKVYIFPMSRGELQQTALLGQAFDKKLVTDEIRALFF
>NZ_CP010429.1|WP_046376075.1|1476642_1477689_-|CRISPR-associated-endonuclease-Cas1
MQLHISTYGTYLHVKDAMFDVRRKGEDGKVINATYSAEKVTHILLATGTMLSTDAVRLAMRHNVDIVFIEQQGDPIGRVWHAKLGSTTKIRKRQLEASLGPDGLRWVRSWLLAKLDNQLGFIRSLKKHRPQHADFLDDKLIRTEALALSINTLASATGSATCVADVADTLRGLEGTAGRLYFETLSYVLPKEYQFNGRSSRPAQDAFNAFLNYGYGMLYGKVEKTLMMAGLDPYVGFLHRDDYNQLSMVYDFIEPYRGWVDEVVFRLFTAKKVNKSHVSEVSGSKTGQSLNTDGKSLLVNAFNEFMDNDPIRYRGRNLVRSHCMQLDAHQFANELIGKTGGLPDLIKL
>NZ_CP010429.1|WP_046376076.1|1477742_1478486_-|CRISPR-associated-endonuclease-Cas6
MTTTPPQTLIPITTITFPEIALRTRDAHKLRGYFGELFKAHSPLLHNHLESDAGTDGGVAVKFRYAYPLVQYKVLNHIPTLVGLGEGATLLTQLFLQMREVQIENQTFPVLSKHIRHEQIPIGIADDLIEYRFETLWMALNQDNFRDYRRYAEAEQQAQLKRVLTSQLLALFREFGLWLQPHERILVRLSVEERTTQFKNQTMVAFTGGFLANVILPDGIGLGKAVSRGFGAIQRVKERMSERVAGT
>NZ_CP010429.1|WP_158500542.1|1478485_1480903_-|CRISPR-associated-helicase-Cas3'
MADSCRLLLQSRVTNFDLPDGLLADVGYLAGVCHDIAKGTRYFQHYLLTPNHERIGPKEHALLSSLLAKQVVTQYLLPFELTSIDRQLLPYLVFTAVKRHHGNLNDFREELSLESKVEILCEQIEVFDDEPLIQEILDKLMTVVSFKFDWQSFKQYVRKKEFVDEYLGVGHRLLRTNGLYAKSDPDTKNRYYYWHQLFYGTLLLSDKSDVILKGITGQGAERPSLSALESYRKRRGFDSPRTALDGLKNQAYHETLANLDRIFSVNQHLYSITLPTGLGKTLTSLAVGLAMQQKLSLLAGRLVITIPFTSIIDQNFSVFQEVFSNPTSDILLKHHHLAEPAYKVKDDTVEDDTEEEKTKKTLDQDKSQFLIETWQSGIVVTTFVQLLESLFSNDKTKLLKLPNLANSVIILDEIQQIKYELWPLIRQAFMTLGERYNCYFILMSATQPLIFTPGEEIQELVPNYKDYFRSPHFNRTKLINRARQEVSFAEFKQDVIDYCIDNPAKNMLVILNTKQSTLDCFKAVSGTLDEEATDVYYLTTLITPFERKRIIDRIKTYKGPKQQVIISTQLIEAGVDVSVHTVFRVRCPLDSIIQAAGRANRYNEKEFASEVFLYNITELKAISGKVYGGDLLVKTDNVLKGVDETDEHGYLELIEAYFKEIKKQADVLVSPYLTALQALDFAKVGAFEFVDEQDTESVYIQLNEEAENLWGQYVDISNEKDLKPYERKRKFALIKARFYEYVVNVPLPYEASGVKAKTIVFDEEKENFFYVSHRKNPSTCYRYEYDDFRNNTGYVPIARQLTYNH
>NZ_CP010429.1|WP_052731085.1|1480950_1481706_-|type-I-B-CRISPR-associated-protein-Cas5
MNDNRLIVFELSGEYGHFRKFNTTTSPLTYPIPTRTALTGVLGAVLGVERETAPGRFTNNVLPVQELFGTDACQLAVQLLAPVKKVNIGFNLLDTGNSFYEIRKSGRTQIEFELLKNPAFRVFVRLKDEGLFDRLADRLINRSHHFTPYLGLSQFTANLQDVRVTRGSVRTATAGYVPVQSTVNLSLLTTTPPIEFDQTAHYYVETMPIELSRDRVVMRYGEVLVNADVGSVMVQANEWFETPDFGNILFL
>NZ_CP010429.1|WP_046376078.1|1481702_1482596_-|type-I-B-CRISPR-associated-protein-Cas7/Csh2
MTTLSNRTEILFLYEIENANPNGDPLNENRPRYDSEENRVLVSDVRLKRTIRDYWYEYKGYNGTDGKDIFVRETTYEDKGKTFVSDGKRRAKAFQESKQTVLDQCIDVRTFGGVLPLDKDSITLVGPTQFQMGKSLNKTDIVTEQGTGAFASGDGKGQATFRTEYKVPYALIGFNGIINEKAAAYSQMTDDDKALLLEGIWEGTKNLISRSKFGQTPLLLITVEYNEPYYIGGLRQRLKLITEKNEMQLRSTDDYTLDVSVLMAELVSQKDKISSVTVRIDPRLKTSQPLTNGLLTL
>NZ_CP010429.1|WP_046376079.1|1482600_1484520_-|TIGR02556-family-CRISPR-associated-protein
MQDKAVAAIGRLALQKSGQAEPYQLYVENMFPGAGVNYDVLLAVFSFTTEDSQLVCRFEGVDTEKANETSYQKYVYRKGAANGGDVTFTTKAGDLAKKLNTLVGNQVKKAIALCRVSNYQYDLGMLLSLQDRLTNDYDTILLALQNAYTLMDKKRQQASGLSFRFEFDGERKYLADFPIFQQQVLLHGTSGKSEKYNVTSQGTNQLCSICLENKPLLHGFASPFKYATVDKPGMVSGFFSRRNNWKNYPICSDCSLDFEYGQKYVAQKLKKYFYGTSYYMIPKTVRSQDKEVLEEALATIDSFEYILKEAGQIRFAEDDLMRLLGDSGGGDAFSLNLMFFEENPTTKAIKIKLLLEEILPSRFRKLFSEVPGKVNPNPLYKGVDGTSKDPSNLTFSFGLFKLFYEDDFYAIVNDVFVGQPINRLTLYGRFMKIIKDSYFNTSFVNKVPQTPKLLILKAHLLLNYLSQLSLITTNQTIHMQSEELTEEIRPDEKYGRAFDEVLFRQFVKDNIGAFLQNDAQVGVFALGVLVKLLLNIQRNKLNGASPFENKLKGYNLNAENLRTIYRETLDKLEKYRKPGKRYDELRQIISDYFIINSHRLSLMPNNELSFYFVAGLEMAYKFRTAKAQTQEELDDQTEN
>NZ_CP010429.1|WP_046376080.1|1484663_1485104_+|hypothetical-protein
MNQPFYEFTSSIEALRYEFTSIGQRVVRKVIIYQELPFPNVYNLALGDTDDQGKADFGITSDNGDRDTILATVIQTLITFFHKYPQASVFIAGSTPSRTRLYQGVINRELGEIQKRFDVLGVTEDGTESFSKGKSYQAFVISLKQL
>NZ_CP010429.1|WP_046376081.1|1485126_1485309_+|hypothetical-protein
MAVIVKKTDRKLPPNHPLSRKFDTVEEAAQAKTDYVWNTVLKDFDWNAFMAKKGNQVSQK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP010429_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP010429_4

3856298-3856399

Orphan

Consensus_repeat	Method
TGTCAGATTCTTAAATCTGGCAGGTGAGGTT	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP010429_4

>merge|NZ_CP010429|4|3856298-3856399|CRISPRCasFinder
TGTCAGATTCTTAAATCTGGCAGGTGAGGTTACTTAAAACCTTGGACTGTTCGGTTTTGAGAAACCTCACCTGTCAGATTCTTAAATCTGACAGGTGAGGTT

>NZ_CP010429|4|4|3856298-3856399|CRISPRCasFinder
TGTCAGATTCTTAAATCTGGCAGGTGAGGTT	ACTTAAAACCTTGGACTGTTCGGTTTTGAGAAACCTCACC
TGTCAGATTCTTAAATCTGACAGGTGAGGTT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP010429.1\|WP_046574911.1\|3849606_3852705_+\|efflux-RND-transporter-permease-subunit	unknown	unknown	gnl\|CDD\|226220
NZ_CP010429.1\|WP_148562548.1\|3844766_3846983_-\|heavy-metal-translocating-P-type-ATPase	unknown	unknown	gnl\|CDD\|319783
NZ_CP010429.1\|WP_046574903.1\|3843026_3843968_+\|ribose-phosphate-pyrophosphokinase	unknown	unknown	gnl\|CDD\|234929
NZ_CP010429.1\|WP_046574909.1\|3847516_3849376_-\|glycoside-hydrolase-family-2	unknown	unknown	gnl\|CDD\|225789
NZ_CP010429.1\|WP_046574917.1\|3855416_3856220_-\|phytanoyl-CoA-dioxygenase-family-protein	unknown	unknown	gnl\|CDD\|368580
NZ_CP010429.1\|WP_046574931.1\|3868882_3870517_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_179945465.1\|3853241_3853919_+\|response-regulator	unknown	unknown	gnl\|CDD\|223816
NZ_CP010429.1\|WP_046574901.1\|3841667_3842846_-\|acyl-CoA-dehydrogenase-family-protein	unknown	unknown	gnl\|CDD\|173838
NZ_CP010429.1\|WP_046574919.1\|3856526_3857810_-\|3-phosphoshikimate-1-carboxyvinyltransferase	unknown	unknown	gnl\|CDD\|238797
NZ_CP010429.1\|WP_046574923.1\|3861283_3864238_+\|TonB-dependent-receptor	unknown	unknown	gnl\|CDD\|238657
NZ_CP010429.1\|WP_046574930.1\|3868231_3868744_+\|peptide-methionine-(R)-S-oxide-reductase-MsrB	unknown	unknown	gnl\|CDD\|376583
NZ_CP010429.1\|WP_046574925.1\|3864935_3866042_-\|bifunctional-diaminohydroxyphosphoribosylaminopyrimidine-deaminase/5-amino-6-(5-phosphoribosylamino)uracil-reductase-RibD	unknown	unknown	gnl\|CDD\|273015
NZ_CP010429.1\|WP_046574905.1\|3844077_3844644_+\|50S-ribosomal-protein-L25/general-stress-protein-Ctc	unknown	unknown	gnl\|CDD\|235534
NZ_CP010429.1\|WP_046574915.1\|3854001_3855420_+\|HAMP-domain-containing-histidine-kinase	unknown	unknown	gnl\|CDD\|223715
NZ_CP010429.1\|WP_046574929.1\|3867191_3868169_+\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|285027
NZ_CP010429.1\|WP_046574920.1\|3858005_3859265_+\|N-acetylglucosamine-6-phosphate-deacetylase	unknown	unknown	gnl\|CDD\|224733
NZ_CP010429.1\|WP_046574927.1\|3866203_3867052_+\|peptide-chain-release-factor-N(5)-glutamine-methyltransferase	unknown	unknown	gnl\|CDD\|236467
NZ_CP010429.1\|WP_046574921.1\|3859272_3860700_-\|tetratricopeptide-repeat-protein	unknown	unknown	gnl\|CDD\|276809
NZ_CP010429.1\|WP_046579622.1\|3864252_3864762_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP010429.1\|WP_046574908.1\|3847077_3847284_-\|heavy-metal-associated-domain-containing-protein	unknown	unknown	gnl\|CDD\|225328

Protein	Function_ID	Function_description	E-value
NZ_CP010429.1\|WP_046574911.1\|3849606_3852705_+\|efflux-RND-transporter-permease-subunit	gnl\|CDD\|226220	COG3696, COG3696, Putative silver efflux pump [Inorganic ion transport and metabolism].	0
NZ_CP010429.1\|WP_148562548.1\|3844766_3846983_-\|heavy-metal-translocating-P-type-ATPase	gnl\|CDD\|319783	cd02094, P-type_ATPase_Cu-like, P-type heavy metal-transporting ATPase, similar to human copper-transporting ATPases, ATP7A and ATP7B. The mammalian copper-transporting P-type ATPases, ATP7A and ATP7B are key molecules required for the regulation and maintenance of copper homeostasis. Menkes and Wilson diseases are caused by mutation in ATP7A and ATP7B respectively. This subfamily includes other copper-transporting ATPases such as: Bacillus subtilis CopA , Archeaoglobus fulgidus CopA, and Saccharomyces cerevisiae Ccc2p. This subclass of P-type ATPase is also referred to as CPx-type ATPases because their amino acid sequences contain a characteristic CPC or CPH motif associated with a stretch of hydrophobic amino acids and N-terminal ion-binding sequences. This subfamily belongs to the P-type ATPases, a large family of integral membrane transporters that are of critical importance in all kingdoms of life. They generate and maintain (electro-) chemical gradients across cellular membranes, by translocating cations, heavy metals and lipids, and are distinguished from other main classes of transport ATPases (F- , V- , and ABC- type) by the formation of a phosphorylated (P-) intermediate state in the catalytic cycle.	0
NZ_CP010429.1\|WP_046574903.1\|3843026_3843968_+\|ribose-phosphate-pyrophosphokinase	gnl\|CDD\|234929	PRK01259, PRK01259, ribose-phosphate diphosphokinase.	0
NZ_CP010429.1\|WP_046574909.1\|3847516_3849376_-\|glycoside-hydrolase-family-2	gnl\|CDD\|225789	COG3250, LacZ, Beta-galactosidase/beta-glucuronidase [Carbohydrate transport and metabolism].	9.40305e-33
NZ_CP010429.1\|WP_046574917.1\|3855416_3856220_-\|phytanoyl-CoA-dioxygenase-family-protein	gnl\|CDD\|368580	pfam05721, PhyH, Phytanoyl-CoA dioxygenase (PhyH). This family is made up of several eukaryotic phytanoyl-CoA dioxygenase (PhyH) proteins, ectoine hydroxylases and a number of bacterial deoxygenases. PhyH is a peroxisomal enzyme catalyzing the first step of phytanic acid alpha-oxidation. PhyH deficiency causes Refsum's disease (RD) which is an inherited neurological syndrome biochemically characterized by the accumulation of phytanic acid in plasma and tissues.	1.82182e-06
NZ_CP010429.1\|WP_179945465.1\|3853241_3853919_+\|response-regulator	gnl\|CDD\|223816	COG0745, OmpR, Response regulators consisting of a CheY-like receiver domain and a winged-helix DNA-binding domain [Signal transduction mechanisms / Transcription].	2.42962e-83
NZ_CP010429.1\|WP_046574901.1\|3841667_3842846_-\|acyl-CoA-dehydrogenase-family-protein	gnl\|CDD\|173838	cd00567, ACAD, Acyl-CoA dehydrogenase. Both mitochondrial acyl-CoA dehydrogenases (ACAD) and peroxisomal acyl-CoA oxidases (AXO) catalyze the alpha,beta dehydrogenation of the corresponding trans-enoyl-CoA by FAD, which becomes reduced. The reduced form of ACAD is reoxidized in the oxidative half-reaction by electron-transferring flavoprotein (ETF), from which the electrons are transferred to the mitochondrial respiratory chain coupled with ATP synthesis. In contrast, AXO catalyzes a different oxidative half-reaction, in which the reduced FAD is reoxidized by molecular oxygen. The ACAD family includes the eukaryotic beta-oxidation enzymes, short (SCAD), medium (MCAD), long (LCAD) and very-long (VLCAD) chain acyl-CoA dehydrogenases. These enzymes all share high sequence similarity, but differ in their substrate specificities. The ACAD family also includes amino acid catabolism enzymes such as Isovaleryl-CoA dehydrogenase (IVD), short/branched chain acyl-CoA dehydrogenases(SBCAD), Isobutyryl-CoA dehydrogenase (IBDH), glutaryl-CoA deydrogenase (GCD) and Crotonobetainyl-CoA dehydrogenase. The mitochondrial ACAD's are generally homotetramers, except for VLCAD, which is a homodimer. Related enzymes include the SOS adaptive reponse proten aidB, Naphthocyclinone hydroxylase (NcnH), and and Dibenzothiophene (DBT) desulfurization enzyme C (DszC).	3.26587e-28
NZ_CP010429.1\|WP_046574919.1\|3856526_3857810_-\|3-phosphoshikimate-1-carboxyvinyltransferase	gnl\|CDD\|238797	cd01556, EPSP_synthase, EPSP synthase domain. 3-phosphoshikimate 1-carboxyvinyltransferase (5-enolpyruvylshikimate-3-phosphate synthase) (EC 2.5.1.19) catalyses the reaction between shikimate-3-phosphate (S3P) and phosphoenolpyruvate (PEP) to form 5-enolpyruvylshkimate-3-phosphate (EPSP), an intermediate in the shikimate pathway leading to aromatic amino acid biosynthesis. The reaction is phosphoenolpyruvate + 3-phosphoshikimate = phosphate + 5-O-(1-carboxyvinyl)-3-phosphoshikimate. It is found in bacteria and plants but not animals. The enzyme is the target of the widely used herbicide glyphosate, which has been shown to occupy the active site. In bacteria and plants, it is a single domain protein, while in fungi, the domain is found as part of a multidomain protein with functions that are all part of the shikimate pathway.	6.2762e-109
NZ_CP010429.1\|WP_046574923.1\|3861283_3864238_+\|TonB-dependent-receptor	gnl\|CDD\|238657	cd01347, ligand_gated_channel, TonB dependent/Ligand-Gated channels are created by a monomeric 22 strand (22,24) anti-parallel beta-barrel. Ligands apparently bind to the large extracellular loops. The N-terminal 150-200 residues form a plug from the periplasmic end of barrel. Energy (proton-motive force) and TonB-dependent conformational alteration of channel (parts of plug, and loops 7 and 8) allow passage of ligand. FepA residues 12-18 form the TonB box, which mediates the interaction with the TonB-containing inner membrane complex. TonB preferentially interacts with ligand-bound receptors. Transport thru the channel may resemble passage thru an air lock. In this model, ligand binding leads to closure of the extracellular end of pore, then a TonB-mediated signal facillitates opening of the interior side of pore, deforming the N-terminal plug and allowing passage of the ligand to the periplasm. Such a mechanism would prevent the free diffusion of small molecules thru the pore.	3.88927e-31
NZ_CP010429.1\|WP_046574930.1\|3868231_3868744_+\|peptide-methionine-(R)-S-oxide-reductase-MsrB	gnl\|CDD\|376583	pfam01641, SelR, SelR domain. Methionine sulfoxide reduction is an important process, by which cells regulate biological processes and cope with oxidative stress. MsrA, a protein involved in the reduction of methionine sulfoxides in proteins, has been known for four decades and has been extensively characterized with respect to structure and function. However, recent studies revealed that MsrA is only specific for methionine-S-sulfoxides. Because oxidized methionines occur in a mixture of R and S isomers in vivo, it was unclear how stereo-specific MsrA could be responsible for the reduction of all protein methionine sulfoxides. It appears that a second methionine sulfoxide reductase, SelR, evolved that is specific for methionine-R-sulfoxides, the activity that is different but complementary to that of MsrA. Thus, these proteins, working together, could reduce both stereoisomers of methionine sulfoxide. This domain is found both in SelR proteins and fused with the peptide methionine sulfoxide reductase enzymatic domain pfam01625. The domain has two conserved cysteine and histidines. The domain binds both selenium and zinc. The final cysteine is found to be replaced by the rare amino acid selenocysteine in some members of the family. This family has methionine-R-sulfoxide reductase activity.	1.40181e-68
NZ_CP010429.1\|WP_046574925.1\|3864935_3866042_-\|bifunctional-diaminohydroxyphosphoribosylaminopyrimidine-deaminase/5-amino-6-(5-phosphoribosylamino)uracil-reductase-RibD	gnl\|CDD\|273015	TIGR00326, eubact_ribD, riboflavin biosynthesis protein RibD. This model describes the ribD protein as found in Escherichia coli. The N-terminal domain includes the conserved zinc-binding site region captured in the model dCMP_cyt_deam and shared by proteins such as cytosine deaminase, mammalian apolipoprotein B mRNA editing protein, blasticidin-S deaminase, and Bacillus subtilis competence protein comEB. The C-terminal domain is homologous to the full length of yeast HTP reductase, a protein required for riboflavin biosynthesis. A number of archaeal proteins believed related to riboflavin biosynthesis contain only this C-terminal domain and are not found as full-length matches to this model. [Biosynthesis of cofactors, prosthetic groups, and carriers, Riboflavin, FMN, and FAD].	2.15178e-84
NZ_CP010429.1\|WP_046574905.1\|3844077_3844644_+\|50S-ribosomal-protein-L25/general-stress-protein-Ctc	gnl\|CDD\|235534	PRK05618, PRK05618, 50S ribosomal protein L25/general stress protein Ctc; Reviewed.	1.74705e-53
NZ_CP010429.1\|WP_046574915.1\|3854001_3855420_+\|HAMP-domain-containing-histidine-kinase	gnl\|CDD\|223715	COG0642, BaeS, Signal transduction histidine kinase [Signal transduction mechanisms].	2.59568e-55
NZ_CP010429.1\|WP_046574929.1\|3867191_3868169_+\|AAA-family-ATPase	gnl\|CDD\|285027	pfam07726, AAA_3, ATPase family associated with various cellular activities (AAA). This Pfam entry includes some of the AAA proteins not detected by the pfam00004 model.	5.25776e-88
NZ_CP010429.1\|WP_046574920.1\|3858005_3859265_+\|N-acetylglucosamine-6-phosphate-deacetylase	gnl\|CDD\|224733	COG1820, NagA, N-acetylglucosamine-6-phosphate deacetylase [Carbohydrate transport and metabolism].	9.03691e-118
NZ_CP010429.1\|WP_046574927.1\|3866203_3867052_+\|peptide-chain-release-factor-N(5)-glutamine-methyltransferase	gnl\|CDD\|236467	PRK09328, PRK09328, N5-glutamine S-adenosyl-L-methionine-dependent methyltransferase; Provisional.	6.16384e-84
NZ_CP010429.1\|WP_046574921.1\|3859272_3860700_-\|tetratricopeptide-repeat-protein	gnl\|CDD\|276809	sd00006, TPR, Tetratricopeptide repeat. The Tetratricopeptide repeat (TPR) typically contains 34 amino acids and is found in a variety of organisms including bacteria, cyanobacteria, yeast, fungi, plants, and humans. It is present in a variety of proteins including those involved in chaperone, cell-cycle, transcription, and protein transport complexes. The number of TPR motifs varies among proteins. Those containing 5-6 tandem repeats generate a right-handed helical structure with an amphipathic channel that is thought to accommodate an alpha-helix of a target protein. It has been proposed that TPR proteins preferentially interact with WD-40 repeat proteins, but in many instances several TPR-proteins seem to aggregate to multi-protein complexes.	0.000342983
NZ_CP010429.1\|WP_046574908.1\|3847077_3847284_-\|heavy-metal-associated-domain-containing-protein	gnl\|CDD\|225328	COG2608, CopZ, Copper chaperone [Inorganic ion transport and metabolism].	0.000251503

>NZ_CP010429.1|WP_046574917.1|3855416_3856220_-|phytanoyl-CoA-dioxygenase-family-protein
MSHREQFEQQGYLIVRNVFTPDEVAKLRQSAYEHRDRQQKLGQVAQVKQAASVKGDLLSKDGLGWVIYDPRIVAIATEILGDTPVYFSDSTYQIGTGTRGFHRDNIDRYQFGQGADWEGPYPLIRFGIYLQNHDSYSGGIRFKAGSHEAADGADVFADTRAGDIVVWNMRTLHSGNARRMKVLTNLPLHVGLENRLPNFLFREQQGERVSLFFSYGLEGKHLDRYLEQHIQKRADMQENVRLSTYSPETLKKAEQNKVKVLDVKKLV
>NZ_CP010429.1|WP_046574915.1|3854001_3855420_+|HAMP-domain-containing-histidine-kinase
MNIRTRLTLLFVLLVASIVLLFTVSVYYLYDQFREQEFQQRLVEKAFTTVRLREDVGEVPRADLPVMTDEQVTIYNRQGTVLYNQETKRPRFPVTPAFLSKVAYQKPQYSRIGDTEAIAVLHLNARKEPLIIVASGNDRYGLSKLDRLREILFSGWLLSLVIVGIAGYLFATDALRPVAELITQVNAISATNIHERLRVGRQRDELADLARTFNDLLTRLEEAFVLQKSFVSHASHELRTPLTVMMGQIEVTRLHARTTEEYEVAFDALLDEVKSMIRLVNGLLELARASSDVVTLNYQPVRIDELLWQAQSQIISKKPDYQIDIDFDNLPVHEEELVIVGEESLLQTAFQNLMENGCKYSPDGCVSVRIFFEPGRLKLTFSDQGYGIPESDLPHIFEPFFRSESTMTIIGHGIGLALTRRIIELHQGHIQVDSVVGKGTTFRITLPTTYTLPQNSGSNINLAKVAAAKPTD
>NZ_CP010429.1|WP_179945465.1|3853241_3853919_+|response-regulator
MKILVVEDEPKLASFVKKGLEEQSCEVDVAYDGQVGRNMALNNLYDVIVLDINLPKMNGFDVVQSIRQEKNRTPVLMLTAMGSVDDKLTGFEAGADDYLVKPFEFRELMARLRALTKRSSDAGMQANVLKVADLELDLNEKIARRGDKRIELTAKEFGLLDYLMRNRGRVVSRVDIAEKVWDIHFDTGTNVIDVYVNFLRKKIDKDFPTKLIHTVIGMGYMLKEE
>NZ_CP010429.1|WP_046574911.1|3849606_3852705_+|efflux-RND-transporter-permease-subunit
MNKFIKSILSFSLKNKFFIFFLTALAVVAGVISYQNTPIEAFPDVTNTQITLITQWPGRSAEEVEKFVTIPIEIGLNSVQKRTDIRSTSLFGLSVVKILFDDGVDDAFARQQVNNLLNGVELPEGIKPDVQPPYGPTGEIFRYTLQSPTRTARELKTMQDWVIERQLKSVPGVADVVSFGGEVKTYEISVDPRRLIDYNITPLQLYQAVANANVNVGGDVIEKNSEAYVVRGIGLLKNQQDIQNIIIKNIKGTPITVHNVAQVSESALPRLGQAGRDKQDDAVECIVVMRKGENPSEVIDRVKAKINELNTSILPSDVEINTFYNRETLINFATHTVTHNLIEGIVFVTVIVFIFMADWRTTVTVSIVIPLALLFAFICLRLKGMSANLLSMGAIDFGIIVDGAVVMVEGIFVTLDELAHEKGMTRFNRLAKMGIIRKTGTEMGKAIFFSKAIIITCLIPIFSFQKVEGKMFSPLAWTLGFALLGALIFTLTLVPVLASILLKKDVREKHNPFVNVVTSFSTRLFNFTFAHKKISMILTGILVAVGLSGFTLLGTEFLPELNEGSIYVRATMPMSISLPESVKQTVQMRHIFEQFPEVKGVISQTGRPNDGTDPTGFYNIEFLVDIYPQDDWKSGLSKEELIEQMQEKLSVFPGVNFGFSQPIMDNVEEAVSGVKGSIAVKIYGPDQGILETKANEIRNQLATVQGIEDLGVIRTTGQPEMRIELDEHKLAVYGVNKADAEAVIEMAIGGKAATQIYEGERKFDLRIRYDRPFRSSESQISQLMVPTENGSMIPIKEIANVYTQTGPVLIFREASQRYGAVKFSVRGRDMGSAVAEAQQKVQANVKLPAGYTAKWAGDFENQQRATARLAQVVPISLLAIFFILFVLFGNVKDAGLVLFNVPFAIIGGIAALLITHVNFSISAGIGFIALFGICIQNGVILISVFKKNLRNSIPLTDAIREGVISRIRPVVMTAMMAGIGLIPAAVSHGIGSETAKPLAIVVIGGLITATLLTLFVFPLIFYSFYRQKFSDI
>NZ_CP010429.1|WP_046574909.1|3847516_3849376_-|glycoside-hydrolase-family-2
MSEIQSNFGLTDSKEEGAAVDEPINPLPRAVLRSNSHWLLDGEWKFSIDANDTGLQDRWFLGHSYEGVAEWPGSIEEHMAHTKGQAGPVIWQDKVIAWYEREFALPDRTEPLANSIIQLTFGACGYETRVWLNGHPLSTVEGEAIHYGEYTSFSYELADELLRPNNRLTVRIADTMDAETPRGKQESHVYKRGGIWYQTYTGAVRSVWLETVERNRLRSRVGVVSTVEDELVRFTLTTRIHDPGNYTLRLQIFERKAPLSSTPMATSDFPLMLEAGQKQQRVVIEVPGAQLWSPENPVRYRLIAQLIDENGYVAQIESQFGLRKIEARGRFVYLNNKPIYLDGILYQPGTATYEEMKRHMLAMKELGCNLVRVHIAGIDPRIYNLADKLGLLLWVEVPSPHSSTSRSRHNHQAELMRMLALIGTHPSVVIWSLYNEDWGAQDIATNPETREYITNMYYFMQLAYPQFLVVDNDGWQHISYEGRLKSDLLTAHLYTPDLGQWQSLLDRLVAGDLDTVAAFPLVVGDPFFYRRQVPLVVSEWGGFGFSNYGGPQDAEERTERIRQFKQEMRKRSIAGDVYTQATNIEDERNGLIEPHTGELTVPARLLASGGYSEVAAMPA
>NZ_CP010429.1|WP_046574908.1|3847077_3847284_-|heavy-metal-associated-domain-containing-protein
METVKFKTNIKCGNCIATVTPFLNEAVGEGNWQVDTTDPKKVLTAKNATAEEVRQAIEKAGYKAEPLN
>NZ_CP010429.1|WP_148562548.1|3844766_3846983_-|heavy-metal-translocating-P-type-ATPase
MSCAACAVSVESILKHTPGVSDAGVNYANQSAWVQFNPGIVSPAELQQAVREMGYDIVIETEESGPDARQVQEDANQKRFQRLKQRTIWAVILSLPIVVIGMFFMSFPNGNYIMMALAAPVVFGLGRPFFANAWKQARHGKANMDTLVALSTGIAFLFSAFNTLYPEFWYRRSGVHPHVYFEAAAVVVTFILLGKLLEERAKQNTSSAIKKLIGLQPKTVWVVEGDTEREIPISAVQVGQLLLVRPGERVPVDGRVASGESYVDESMISGEPVPVLKQSGGGVFAGTINQKGSFRFYAEKVGSNTLLAQIIRMVQEAQGSKAPVQQLVDRIAGVFVPVVLGIAVLTFAVWMVFGYYLAPNSDPFTTALLTSVAVLVIACPCALGLATPTAIMVGVGKGAENNILIKDAESLEMAHTVNAVVLDKTGTITEGKPFVTDMHWAVPANEQAPLTSILYSLEKQSEHPLAEAVTAFLPTHESLPLDSFDSVTGRGVRATYQHIVYFTGNKSLLRENQITIPAELEQYAAGLQSQAKTLIYFARKNEVNGQVLALLAIADPVKPSSKQAIDTLQNRGIEVYMLTGDNGQTAAAVAEQVGIHHFKADVMPGDKADFVSALQASGKVVAMVGDGINDSQALAQADVSIAMGKGSDIAMDVARMTLITSDLTSLSRAFNLSRQTVRVVRQNLFWAFIYNLIGIPIAAGVLFPAFGFLLNPMIAGAAMALSSVSVVSNSLRLRGMKL
>NZ_CP010429.1|WP_046574905.1|3844077_3844644_+|50S-ribosomal-protein-L25/general-stress-protein-Ctc
MKKIEIVGYQRANLGRTESQAIRAEGNVPCVLYGGEEQVHFYAPAILFRDLIYSPNIFEVALNIEGAEYRAILQEAQFHPVSDILLHADFLLITDNKPIKIAVPVRLLGTAPGVQKGGKLVTRVRKLRVKGTVENIPDYIDVDVSGLDLGKSVRVGQISVQNIELLEEASNPVASIEIPRALRGTVGK
>NZ_CP010429.1|WP_046574903.1|3843026_3843968_+|ribose-phosphate-pyrophosphokinase
MASFNPVKIFSGSQSTYLAEKIAHYYGKDLGGYTCRRFSDGEMSPSFEESVRGCDVFLIQSTPPPADNLLELMLMVDAARRASAHYVTVVIPYFGYARQDRKDKPRVSIAAKLVANTLAASGVDRLMTIDLHAGQIQGFFDFPVDHLEGTSVFVPYIRSLNLENLVVASPDVGGANRARTFAKHFNADIVLCDKHRKRANEIASMQVIGDVEGANVVLVDDLIDTGGTMAKAAQIIMDKGALSVRAVCTHPIMSGKAHENIANSVLQELVVADTLPMKQTNEKIRVLSVAELFAKAIGRIRDHESISSLFIKY
>NZ_CP010429.1|WP_046574901.1|3841667_3842846_-|acyl-CoA-dehydrogenase-family-protein
METLNPFQPVGLAPKPLLGLDSEPIAALCKQIADAAAQTDDDKTFPEEAFSRLAEAGLLAVTLPGRQLDSRSPKTSQLLQLLKRIGAANLSVGRVYEGHINALNLIHLYATQEQKTRWYADVSQYKRLFSVWNTQAADGIKIHALANGRYRLEGAKTFCSGSGWIQRPLITGQLLGDPSGQGWQMCIIPTERVDAIAQDTSFWQPLGMRASVSYKLDFTGLEISREDLLGQPDDYYRQPYFSGGASRFAAVQLGGAEALFNATRALLASMNRTDDPIQRTRLAEMAWLIESGNQWLKAAGENTDAWLADENETEKIVAYTNMTRTAIEEICLRVMPLAERSVGARGLMRPLPFERIHRDLTFYLRQPAPDATVLDIGRYVLDNPQNAHELWR
>NZ_CP010429.1|WP_046574919.1|3856526_3857810_-|3-phosphoshikimate-1-carboxyvinyltransferase
MNAVRLTPPATLTQPGLVQATIPLASSKSESNRALIIDALTGFRCDLQNLSTARDTQTMIRLLKSTDPTADVLDAGTTMRFLTAYFAATGQEKIMTGTPRMCERPIGILVDALRALGANITYLKQEGYPPLQIKGFSSSTESSNRLSIRGDVSSQYISALVMIAPLLPNGLTLELTGAIGSRPYIEMTLEQMRYFGADVQDDWEAKTITVAPKPYTPKPYSIESDWSGASYWYSVAALANDETAEINLLGLKAKSLQGDSAIADIMRSLGVESTFTDSGVRLTKGPAATSLAWDFTDCPDLAQTVAVCAAMKGVVLRLTGIESLKIKETDRVAALQAELQKIGAELVEIEPNHLYEVHQLAVRPSGPPTIATYDDHRMAMAFAPVAMQHEIIIDEPGVVAKSYPSFWDDMARVATVKFTEASTDVTH
>NZ_CP010429.1|WP_046574920.1|3858005_3859265_+|N-acetylglucosamine-6-phosphate-deacetylase
MPILFTNAHLFTGTEWLPNASVRIADDRIQEINPATPVPSDDETTTVIDLKGDYLIPGLVDLQLYGGSDLFLNDQPTPETVRHIYDSHSRNGTTTLLPTIHSTSLAIMQESMAAVQVVRTENPFGVPGIHVEGPYFNPIKRGAHSTAYVRTPADGELETLFSTNADVIRILTLAPEILTPDQLDTIKRLKHTNTLLSLGHSNATYQQATAAFNEGIPLATHLYNAMRGFESREPGVVGAVFDHPTVRASIIADGYHCDPTTIRIAYRLLCQEGKPERLFLISDALFANPPRPNFELGQFIVHFEPDPSRPGPSRPGPSRPGPSRPGPSRPGPSRPGRYVNNEGNLAGSAITLIDCVKIAVEQAGIPLTNALRMASVIPAEIIGMGDQLGKIQPDYIANLVRLDQSMNVNGVWALGKPIA
>NZ_CP010429.1|WP_046574921.1|3859272_3860700_-|tetratricopeptide-repeat-protein
MNYLFSIILLFACSLSALAQNARDAVEAQHFIKLGNTLRMVDRPEQAIDLLLRSLPAVKAKDPYLEAVAYENLGFAYRDQENSQTALGYFHKAQTLYKKLNFGASEAAMRQLISETASKDLYAGIDVGASGVKLAIFRTIYENGFYNKDVKVKPIAPNVTLVSGTAQSFKDGQEVMKAYLDSIRRYNIPADHIYVAFSSGVNETLGKTPEKKKKLYELFSALVTNSLPGSDSLFIDSTLTAAREAELFMIGSIPRKLWLTASCVDIGSGNTKGGYYDSGHRFHSVSLPVGTKTMANLIDNNRSLPIEDYKKEAQRVIKMMADTAINVEFNTTSPGLHQRRTVALGGGIVWAMAAYLHPEKAGTTAVPLTLADAEHFARLAMTDYQSLIHPDLSDLTDPVVRRKAEADLVNVQNQFNEKQLIAGSLLLEAVIRAYADTSIPKRFVFIRDSDISWVTGKFLETLNQNYEKAIARDAR
>NZ_CP010429.1|WP_046574923.1|3861283_3864238_+|TonB-dependent-receptor
MKRKLRKHHLLPALVALFIMVALFPVETLAQSRKITGKVSTSGSTEVLQGVNVLVKGNTRKGAVTDGQGMFALEASPTDVLVISFIGFKSKEIKVGNETTFNISLDEDATQLTELIVTGSRNTGRTILETPVPVDVISIKDIMGELPQMDLAQMLAFVAPSFNAVRSQGGDLNSHVDPVQLRNMAPNQILVLVNGKRRHTSALLITETAVGSPSTTVDLMTIPVSAIDRVEILRDGAAAQYGSDAVAGVVNIILKKGTNKLTGSLTGGGYANTGGQAGALTKSGKPDGFNYQFDANYGFKISDKGYFNVSGQITQRRPTLRPFVNDWGFFDNTYLNNLRTDKNGNPVITNPELINAQVAGNTSQIAALKTETGLMSARGLTKADFAVYAGMPAITLGSTFYNAGYEINPTTTIYSFGGASYKYLEGFSCYFRRPAQTDRFNYLLYPNGFRPQMTSNTSDMSNTIGLKSKIGDFSVDFSNTFGRNTMRLGMVNTFNASLGSNSPVNMNLGTHQFSQNSTNLDLSRYFKGVMNGLNIAFGAEMRIENYKIIKGQEESYAYGNAGVLTAVKDGLLVGPDGKPLEDANSIPIVDASGNPLSVFAGQQVTVKSLSSNCQCFAGFGPKNERNEFRTTMAAYLDAELELTRKFLLAGAFRLENYSDFGGVTIGKLAARYSLTKTLSIRGSIATGFRAPSLQELNYTHTATAFVPDANGIPQPLDVTTYPTNSTAARVLGIKGLKQEQSRTYGFGLTYQPAPGFEVTLDAYQIDVDNRIFRTSYFNAAEVGNNYQEVIGDGEAQFFVNGADVRSKGLEAVGNYTLNLQKGSSITFSLAAIFSKNTVLNRKTLDLNVANLTSEQIVGKYLSRDVIGQFETGTPRTKLIGSVSYRVNKFNTMLRGTYFGTVTERSVSSDNDGNFYDQTFSGQAVFDLSFGYDLNRNVKVSIGGSNIFDKYPQILRPENQGFYLYSNNQQGSNGAYYYGRLMFNF
>NZ_CP010429.1|WP_046579622.1|3864252_3864762_+|hypothetical-protein
MNRFFNRRNSIAVLGIFFSLVAFLSSCEQEKFEPNTSVAPGGGTITTFKSYTLTSAPGTTVYGRVVFYKYNSTVTLIEVGLYNTATGTPYTASIYEGKATDSAAKALKPLDTISGATGEFSTNKYYTISEAGFYDKLNAYNANVKIMAGSSLVASGNIGSNATPVAQSQ
>NZ_CP010429.1|WP_046574925.1|3864935_3866042_-|bifunctional-diaminohydroxyphosphoribosylaminopyrimidine-deaminase/5-amino-6-(5-phosphoribosylamino)uracil-reductase-RibD
MSTGIDERFMLRALELATLGRGQVSPNPMVGCVITHESGATEPRIIGEGWHQRYGDWHAEVNAVRSVRPEDRHLLPEATVYVTLEPCSHWGKTPPCADLLIENRVKRVICCNDDPNPLVSGQGFAKLRAAGISVETGLLAEQGRQVNARFFTFFERKRPYIVLKWAETSDGFIAGEQGRQVSISGELAHRLVHRWRSEEPAIMVGANTARLDNPRLNVRLWPGLDGPSLDGPSKSSQNPTRIVLDSQLSLDHSLHLFDGSQLTMVYHRVEDKNESGLPNVTYSFVPENAGSSLSHVLDDLYQRKIQSVLVEGGTRLLTSFIEAGLWDEMRVFRSQAMLGTGIAAPQVRGKLSSRETIGKDELTIYVNA
>NZ_CP010429.1|WP_046574927.1|3866203_3867052_+|peptide-chain-release-factor-N(5)-glutamine-methyltransferase
MATAKPLYERLSKNITAYAPEEAREMAFMLLDHYFGLRKTDVLTDKPLPPNRTEPDWFKILERLNRQEPIQHVIGTTIFCGLEFEVSPDVLIPRPETEDLVRLIMHDFADRVDDVPILDIGTGSGCIAITLARFLPQSVVTGWDVSSEALTLARQNAENLHADVEFAIQDILNIPADFSRQFDCVVSNPPYVTRSEAADMDRNVLDYEPDLALFVEDNDPLVFYKAVADFCVRHLTKDGACYVEINERFGEATRQVFADRGFTKINVYKDIHGKDRSIRITF
>NZ_CP010429.1|WP_046574929.1|3867191_3868169_+|AAA-family-ATPase
MQSTTSFTYHTKIREVFNEMSQVVVGQDRLLNRLLIGLFTGGHILLEGVPGLAKTLTINTLAKVLELDFQRIQFTPDLLPADLIGTMIFNQKTAEFEVKQGPIFANLILADEVNRSPAKVQAALLEAMQEKQVTIGEETFVLDRPFLVLATQNPVEQEGTYPLPEAQVDRFMMKVFVDYLNKEDELAVMRRMSNMNFDYEVQPVLGKEELAAIRDEINGITISETLERYIIELVFATRRPMEFNLRDEARYIQFGVSPRASINLNLAAKALAYFDRRDYVLPEDIKEVAPDVFNHRIMLNYEAEADGVTTLQVIDSILRKVAIGR
>NZ_CP010429.1|WP_046574930.1|3868231_3868744_+|peptide-methionine-(R)-S-oxide-reductase-MsrB
MPQNRIFILIAVLLIAGLWIYGTFIAKPRPPHQRPAGTTSPGNRRVEKTDADWKNQLTRSQYNVARDRGTEWPNSSQLTHEHRQGVYACVCCHNPLFTSATKFDSHTGWPSFYAPIVANAVYNEPDGGRTEVRCSVCDAHLGHVFADGPEPTGLRYCMNGVAMVFEERTN
>NZ_CP010429.1|WP_046574931.1|3868882_3870517_-|hypothetical-protein
MNHFASASSWSFLKALFILTTVGLAVGCQEISDIKNIDPLKGVVFKLNYQPAKAQVQGLVVDAKTGMPLDIPIQVSIQGKDAGRTVTFDGKALTTYTAPKGDLFIGLKGEVPTATAPAELRVVVNAAGYVASGVNLTLKRALNDAFIIRLVKIMATPAGVAAKVDEVTASAAGVLTVDKLIQVTTPASASVASMAMSVFFSAGTVVKDSKGQPVTGKIPTSLVAYSGQSQEALQAFPGGLNAPVAKDVQGRTDIKGIFDPIGFVAIDMKKSTNQAVSAFSKPVTLQMSIPANRFNSSTGQPVKEGDRLEVYSYSETTGVWTFEREVLAERKGNDLMANVPINHLSYYALTIPRTSTTCRVTYTVRGLPEGYSVNYTLRKFDQGLSGSSVVVSSGNSSDNTADRVFEFDVPAGNYEFSILDPVSNNDVMSSTKATNPCGAISLNVTPPARVDASFTVRAKCENGNNIEVYPTVTIFYGEVGKAYSGGSASFVNGKGVLKGLKPNAKYQACIHYEGEYCVEFTMTDASSERTLDYILKANSPTCNN

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity
NZ_CP010429_4	4.1\|3856329\|40\|NZ_CP010429\|CRISPRCasFinder	3856329-3856368	40	NZ_CP010429.1	3856391-3856430	0	1.0

1. spacer 4.1|3856329|40|NZ_CP010429|CRISPRCasFinder matches to position: 3856391-3856430, mismatch: 0, identity: 1.0

acttaaaaccttggactgttcggttttgagaaacctcacc	CRISPR spacer
acttaaaaccttggactgttcggttttgagaaacctcacc	Protospacer
****************************************

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity

Prophage detection

Region

Region Position

Protein_number

Hit_taxonomy

Key_proteins

Att_site

Prophage annotation

DBSCAN-SWA_1

5075512 : 5135848

uncultured_Mediterranean_phage(25.0%)

tRNA,transposase,integrase

attL 5079259:5079311|attR 5135997:5136049

The bacterium proteins that are colored denote the protein is present at specific phage-related keywords (such as 'capsid', 'head', 'integrase', 'plate', 'tail', 'fiber', 'coat', 'transposase', 'portal', 'terminase', 'protease' or 'lysin' and 'tRNA')

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_046576390.1\|5075512_5076643_-\|tRNA	tRNA guanosine(34) transglycosylase Tgt	A0A1B1IVQ4	uncultured_Mediterranean_phage	1.1e-77	41.9
WP_082111750.1\|5076566_5078012_+	glycosyltransferase	NA	NA	NA	NA
WP_179945469.1\|5078085_5078715_+	16S rRNA (guanine(527)-N(7))-methyltransferase RsmG	NA	NA	NA	NA
WP_046576393.1\|5078835_5079138_+	hypothetical protein	NA	NA	NA	NA
5079259:5079311	attL	NA	NA	NA	NA
WP_052731235.1\|5079572_5080217_-\|transposase	IS5 family transposase	NA	NA	NA	NA
WP_046576396.1\|5082658_5083183_+	hypothetical protein	NA	NA	NA	NA
WP_148562477.1\|5083383_5083575_-	hypothetical protein	NA	NA	NA	NA
WP_046576397.1\|5084070_5084946_-	cupin-like domain-containing protein	NA	NA	NA	NA
WP_046576399.1\|5084935_5086837_-	B12-binding domain-containing radical SAM protein	NA	NA	NA	NA
WP_046576400.1\|5086848_5087124_-	hypothetical protein	NA	NA	NA	NA
WP_046576402.1\|5087400_5088276_-	hypothetical protein	NA	NA	NA	NA
WP_046576403.1\|5088299_5088590_-	hypothetical protein	NA	NA	NA	NA
WP_046576406.1\|5089346_5090894_+	alpha/beta hydrolase	NA	NA	NA	NA
WP_148562478.1\|5091299_5092286_+	hypothetical protein	NA	NA	NA	NA
WP_046576409.1\|5092758_5093469_-	trypsin-like peptidase domain-containing protein	NA	NA	NA	NA
WP_082111644.1\|5093651_5093759_-	hypothetical protein	NA	NA	NA	NA
WP_046576411.1\|5094855_5095953_+	hypothetical protein	NA	NA	NA	NA
WP_046576413.1\|5095958_5097110_-	cysteine desulfurase	H7BUW1	unidentified_phage	7.5e-26	35.8
WP_082111645.1\|5097254_5098259_+	DUF4007 family protein	NA	NA	NA	NA
WP_046576416.1\|5098251_5101701_+	hypothetical protein	NA	NA	NA	NA
WP_046576418.1\|5101750_5104117_+	sensor histidine kinase	NA	NA	NA	NA
WP_046576420.1\|5104124_5106101_+	hypothetical protein	NA	NA	NA	NA
WP_046576421.1\|5106090_5106915_+	phosphoadenosine phosphosulfate reductase family protein	A0A0F7L647	uncultured_marine_virus	7.8e-25	33.6
WP_046579886.1\|5106939_5108817_+	hypothetical protein	NA	NA	NA	NA
WP_046576422.1\|5108886_5110434_+	hypothetical protein	NA	NA	NA	NA
WP_148562563.1\|5110957_5115772_+	DNA translocase FtsK	A0A0A0RUH6	Bacillus_phage	2.4e-33	32.7
WP_046576425.1\|5116092_5116524_-	hypothetical protein	NA	NA	NA	NA
WP_158500580.1\|5116871_5117042_-\|integrase,transposase	DDE-type integrase/transposase/recombinase	NA	NA	NA	NA
WP_148562479.1\|5117697_5117802_-\|transposase	transposase	NA	NA	NA	NA
WP_052731237.1\|5117885_5118401_-	hypothetical protein	NA	NA	NA	NA
WP_046576427.1\|5118537_5120040_-	hypothetical protein	NA	NA	NA	NA
WP_052731238.1\|5120394_5120754_-	helix-turn-helix domain-containing protein	NA	NA	NA	NA
WP_158500581.1\|5121392_5121569_+	hypothetical protein	NA	NA	NA	NA
WP_148562480.1\|5121787_5122381_+	hypothetical protein	NA	NA	NA	NA
WP_082111646.1\|5122567_5124586_+	caspase family protein	NA	NA	NA	NA
WP_082111647.1\|5124910_5125174_+\|integrase,transposase	DDE-type integrase/transposase/recombinase	NA	NA	NA	NA
WP_052731239.1\|5125137_5125413_+\|transposase	transposase	NA	NA	NA	NA
WP_046576432.1\|5125895_5126849_-	hypothetical protein	NA	NA	NA	NA
WP_082111648.1\|5126852_5128205_-	CHASE2 domain-containing protein	NA	NA	NA	NA
WP_046576435.1\|5128485_5131557_-	caspase family protein	NA	NA	NA	NA
WP_046576436.1\|5131562_5133164_-	hypothetical protein	NA	NA	NA	NA
WP_046576438.1\|5134594_5135848_-\|integrase	site-specific integrase	NA	NA	NA	NA
5135997:5136049	attR	NA	NA	NA	NA

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage

Overview of predicted results

Overview of the results

Cas Category Instructions

Results visualization

1. NZ_CP010429

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Self-targeting detection

MGE targeting detection<

Prophage detection

Anti-CRISPR protein detection